
==== Front
BMC Endocr Disord
BMC Endocr Disord
BMC Endocrine Disorders
1472-6823
BioMed Central London

718
10.1186/s12902-021-00718-5
Research Article
Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules
https://orcid.org/0000-0003-2571-5734
Prashanth G. 1
https://orcid.org/0000-0003-2202-7637
Vastrad Basavaraj 2
https://orcid.org/0000-0001-8076-928X
Tengli Anandkumar 3
https://orcid.org/0000-0003-3615-4450
Vastrad Chanabasayya channu.vastrad@gmail.com

4
https://orcid.org/0000-0003-1988-7345
Kotturshetti Iranna 5
1 Department of General Medicine, Basaveshwara Medical College, Chitradurga, Karnataka 577501 India
2 Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103 India
3 grid.411962.9 0000 0004 1761 157X Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru and JSS Academy of Higher Education & Research, Mysuru, Karnataka 570015 India
4 Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad, Karnataka 580001 India
5 Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 582209 India
26 4 2021
26 4 2021
2021
21 804 12 2020
2 3 2021
© The Author(s) 2021
https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background

Obesity associated type 2 diabetes mellitus is a metabolic disorder ; however, the etiology of obesity associated type 2 diabetes mellitus remains largely unknown. There is an urgent need to further broaden the understanding of the molecular mechanism associated in obesity associated type 2 diabetes mellitus.

Methods

To screen the differentially expressed genes (DEGs) that might play essential roles in obesity associated type 2 diabetes mellitus, the publicly available expression profiling by high throughput sequencing data (GSE143319) was downloaded and screened for DEGs. Then, Gene Ontology (GO) and REACTOME pathway enrichment analysis were performed. The protein - protein interaction network, miRNA - target genes regulatory network and TF-target gene regulatory network were constructed and analyzed for identification of hub and target genes. The hub genes were validated by receiver operating characteristic (ROC) curve analysis and RT- PCR analysis. Finally, a molecular docking study was performed on over expressed proteins to predict the target small drug molecules.

Results

A total of 820 DEGs were identified between healthy obese and metabolically unhealthy obese, among 409 up regulated and 411 down regulated genes. The GO enrichment analysis results showed that these DEGs were significantly enriched in ion transmembrane transport, intrinsic component of plasma membrane, transferase activity, transferring phosphorus-containing groups, cell adhesion, integral component of plasma membrane and signaling receptor binding, whereas, the REACTOME pathway enrichment analysis results showed that these DEGs were significantly enriched in integration of energy metabolism and extracellular matrix organization. The hub genes CEBPD, TP73, ESR2, TAB1, MAP 3K5, FN1, UBD, RUNX1, PIK3R2 and TNF, which might play an essential role in obesity associated type 2 diabetes mellitus was further screened.

Conclusions

The present study could deepen the understanding of the molecular mechanism of obesity associated type 2 diabetes mellitus, which could be useful in developing therapeutic targets for obesity associated type 2 diabetes mellitus.

Keywords

obesity associated type 2 diabetes mellitus
differentially expressed gene
pathway
protein-protein interaction network
miRNA-target genes regulatory network
issue-copyright-statement© The Author(s) 2021
==== Body
Introduction

Obesity associated type 2 diabetes is one of the most common metabolic disorder worldwide [1]. Type 2 diabetes mellitus is characterized by insulin deficiency due to pancreatic β-cell inactivation and insulin resistance [2]. Genetic factors, hyperinsulinemia, atherogenic dyslipidemia, glucose intolerance, hypertension, prothrombic state, hyperuricemia and polycystic ovary syndrome are the key risk factors for the occurrence and progression of type 2 diabetes mellitus [3]. Obesity associated type 2 diabetes mellitus affects the vital organs such as heart [4], brain [5], kidney [6] and eye [7]. Etiology and advancement of obesity associated type 2 diabetes mellitus is more complex and still understandable. Therefore, it is essential to understand the precise molecular mechanisms associated in the progression of obesity associated type 2 diabetes mellitus and thus to establish valid diagnostic and therapeutic strategies.

Current evidence has shown that genetic predisposition plays a key role in the advancement of obesity associated type 2 diabetes mellitus [8]. Recently, several genes and pathways have been found to participate in the occurrence and advancement of obesity associated type 2 diabetes mellitus [9], including FGF21 [10], pro-opiomelanocortin (POMC) [11], PI3K/AKT pathway [12] and JAK/STAT pathway [13]. However, the current knowledge is insufficient to explain and understand how these crucial genes and signaling pathways are associated with advancement of obesity associated type 2 diabetes mellitus. Therefore, there is a great need to find new prognostic and diagnostics biomarkers, and to advance novel techniques to enlighten the molecular mechanisms controlling the progression of obesity associated type 2 diabetes mellitus.

Bioinformatics analysis of expression profiling by high throughput sequencing data has shown great promise to discover potential key genes and signaling pathways with significant roles in metabolic disorder [14], to identify new prognostic and diagnostics biomarkers, and biological processes implicated in obesity associated type 2 diabetes mellitus. In this investigation, using bioinformatics analysis, we aimed to investigate expression profiling by high throughput sequencing data to determine differentially expressed genes (DEGs) and significant pathways in obesity associated type 2 diabetes mellitus. After searching the Gene Expression Omnibus (GEO) database [15], we selected RNA sequencing dataset GSE143319 for identifying DEGs for obesity associated type 2 diabetes mellitus. This dataset gives more information about obesity associated type 2 diabetes mellitus elevates patient’s risk of nonalcoholic steatohepatitis (NASH), cardiovascular disease and cancer. Gene Ontology (GO) and pathway enrichment analysis were performed. A hub and target genes were identified from protein-protein interaction (PPI) network, modules, miRNA-target genes regulatory network and TF-target gene regulatory network. Subsequently, hub genes were validated by using receiver operating characteristic (ROC) curve and RT- PCR analysis. Finally, molecular docking studies performed for prediction of small drug molecules.

Materials and Methods

RNA sequencing data

The expression profiling by high throughput sequencing dataset GSE143319 deposited by Ding et al [16] into the GEO database were obtained on the GPL20301 platform (Illumina HiSeq 4000 (Homo sapiens)). This dataset is provided for 30 samples, including 15 samples of metabolically healthy obese and 15 samples of a metabolically unhealthy obese.

Identification of DEGs

The limma [17] in R bioconductor package was utilized to screen DEGs between metabolically healthy obese and metabolically unhealthy obese. These DEGs were identified as important genes that might play an important role in the development of obesity associated type 2 diabetes mellitus. The cutoff criterion were ∣log fold change (FC)∣ > 0.2587 for up regulated genes, ∣log fold change (FC)∣ < -0.2825 for down regulated genes and adjusted P value < 0.05.

GO and pathway enrichment analyses

ToppGene (ToppFun) (https://toppgene.cchmc.org/enrichment.jsp) [18], which is a useful online database that integrates biologic data and provides a comprehensive set of functional annotation information of genes as well as proteins for users to analyze the functions or signaling pathways. GO (https://geneontology.org/) [19] enrichment analysis (biologic processes [BP], cellular components [CC], and molecular functions [MF]) is a strong bioinformatics tool to analyze and annotate genes. The REACTOME (https://reactome.org/) [20] is a pathway database resource for understanding high-level gene functions and linking genomic information from large scale molecular datasets. To analyze the function of the DEGs, biologic analyses were performed using GO and REACTOME pathway enrichment analysis via ToppGene online database.

PPI network construction and module analysis

IMEX interactome (https://www.imexconsortium.org/) [21] online PPI database was using to identify the hub gene information in PPI network. Analyzing the interactions and functions of DEGs might give information about the controlling the progression of obesity associated type 2 diabetes mellitus. Cytoscape (version 3.8.2) (www.cytoscape.org) is a bioinformatics platform for constructing and visualizing PPI network [22]. Therefore, the topological properties includes node degree [23], betweenness centrality [24], stress centrality [25], closeness centrality [26] are analyzed in using Java plug-in Network Analyzer to obtain hub genes in the PPI network. The plug-in PEWCC1 of Cytoscape was applied to detect densely connected regions in PPI network. The significant modules in the PPI network was selected using PEWCC1 (https://apps.cytoscape.org/apps/PEWCC1) [27]. The criteria for selection were set as follows: Max depth = 100, degree cut-off = 2, node score cut-off = 0.2, PEWCC1 scores >5, and K-score = 2.

Target gene – miRNA regulatory network construction and analysis

Obesity associated type 2 diabetes mellitus relating miRNAs and experimentally validated target genes were identified from miRNet database (https://www.mirnet.ca/) [28]. Obesity associated type 2 diabetes mellitus relating miRNAs and target genes were identified through target genes - miRNA regulatory network. Then the target genes - miRNA regulatory network was constructed and visualized by using Cytoscape software.

Target gene – TF network regulatory construction and analysis

Obesity associated type 2 diabetes mellitus relating TFs and experimentally validated target genes were identified from TFs database NetworkAnalyst database (https://www.networkanalyst.ca/) [29]. Obesity associated type 2 diabetes mellitus relating TFs and target genes were identified through target genes - TF regulatory network. Then the target genes -TF regulatory network was constructed and visualized by using Cytoscape software.

Receiver operating characteristic (ROC) curve analysis

The ROC curve was used to calculate classifiers in bioinformatics applications. To further assess the predictive accuracy of the hub genes, ROC analysis was performed to discriminate metabolically healthy obese from metabolically unhealthy obese. ROC curves for hub genes were generated using pROC in R [30] based on the obtained DEGs and their expression profiling by high throughput sequencing dataset. The area under the curve (AUC) was evaluated and used to compare the diagnostic value of hub genes.

Validation of the expression levels of candidate genes by RT-PCR

Quantitative RT-PCR was conducted to validate the expressions of these hub genes in obesity associated type 2 diabetes mellitus. Total RNAs were extracted from Primary Subcutaneous Pre adipocytes; Normal Human cell line (ATCC® PCS-210-010™) and 3T3-L1 cells (ATCC® CL-173) using TRI Reagent® (Sigma, USA) according to instruction, followed by reverse transcription with Reverse transcription cDNA kit (Thermo Fisher Scientific, Waltham, MA, USA) and cDNA amplification through 7 Flex real-time PCR system (Thermo Fisher Scientific, Waltham, MA, USA). The expressions of hub genes were normalized to against beta actin expression. The data were calculated by the 2−ΔΔCt method [31]. A primer used in the current investigation was listed in Table 1. Table 1 The sequences of primers for quantitative RT-PCR

Genes	Forward Primers	Reverse Primers	
CEBPD	CGGACTTGGTGCGTCTAAGATG	GCATTGGAGCGGTGAGTTTG	
TP73	CCACCACTTTGAGGTCACTTT	CTTCAAGAGCGGGGAGTACG	
ESR2	AGCACGGCTCCATATACATACC	TGGACCACTAAAGGAGAAAGGT	
TAB1	AACTGCTTCCTGTATGGGGTC	AAGGCGTCGTCAATGGACTC	
MAP 3K5	CTGCATTTTGGGAAACTCGACT	AAGGTGGTAAAACAAGGACGG	
FN1	CGGTGGCTGTCAGTCAAAG	AAACCTCGGCTTCCTCCATAA	
UBD	CCGTTCCGAGGAATGGGATTT	GCCATAAGATGAGAGGCTTCTCC	
RUNX1	CTGCCCATCGCTTTCAAGGT	GCCGAGTAGTTTTCATCATTGCC	
PIK3R2	AAAGGCGGGAACAATAAGCTG	CAACGGAGCAGAAGGTGAGTG	
TNF	CCTCTCTCTAATCAGCCCTCTG	GAGGACCTGGGAGTAGATGAG	

Molecular docking studies

The Surflex-Docking docking studies for the designed molecules were performed using module SYBYL-X 2.0 perpetual software. Using ChemDraw Tools, the molecules were sketched and imported and saved into sdf format using open free software from Babel. The co-crystallised protein structures of CEBPD, TP73, ESR2, TAB1 and MAP 3K5 of its PDB code 3L4W, 2XWC, 1U3Q, 5NZZ & 2CLQwas extracted from Protein Data Bank [32–36]. Together with the TRIPOS force field, GasteigerHuckel (GH) charges were added to all designed derivatives for the structure optimization process. Furthermore, energy minimization was carried out using MMFF94s and MMFF94 algorithm process. The processing of protein was accomplished after the incorporation of protein. The co-crystallized ligand and all water molecules were expelled from the crystal structure; more hydrogen was added and the side chain was optimized. TRIPOS force field was used to minimize complexity of structure. The interaction efficiency of the compounds with the receptor was expressed in kcal / mol units by the Surflex-Dock score. The best spot between the protein and the ligand was inserted into the molecular region. The visualization of ligand interaction with receptor is done by using discovery studio visualizer.

Results

Identification of DEGs

As presented in the cluster heat map of Fig. 1, total 820 DEGs, comprising 409 up regulated and 411 down regulated genes, were identified between metabolically healthy obese samples and metabolically unhealthy obese samples. DEGs were illustrated by volcano plot (Fig.2), and the top up regulated and down regulated DEGs are listed in Table 2. Fig. 1 Heat map of differentially expressed genes. Legend on the top left indicate log fold change of genes. (A1 – A15 = metabolically healthy obese samples; B1 – B15 = metabolically unhealthy obese samples)

Fig. 2 Volcano plot of differentially expressed genes. Genes with a significant change of more than two-fold were selected. Green dot represented up regulated significant genes and red dot represented down regulated significant genes

Table 2 The statistical metrics for key differentially expressed genes (DEGs)

Gene
Symbol	logFC	pValue	adj. P.Val	tvalue	Regulation	Gene Name	
SNORD116-16	2.091053	0.012212	0.012212	2.677149	Up	small nucleolar RNA, C/D box 116-16	
SULT1C2	1.67612	0.002928	0.002928	3.255886	Up	sulfotransferase family 1C member 2	
HLA-DQA1	1.62492	0.022453	0.022453	2.41454	Up	major histocompatibility complex, class II, DQ alpha 1	
SNORD9	1.51914	0.032752	0.032752	2.245	Up	small nucleolar RNA, C/D box 9	
SPX	1.459547	0.00259	0.00259	3.303822	Up	spexin hormone	
FXYD6-FXYD2	1.421933	0.001908	0.001908	3.42214	Up	FXYD6-FXYD2 readthrough	
LOC102724951	1.41856	0.047463	0.047463	2.072149	Up	uncharacterized LOC102724951	
SNORA11B	1.378113	0.039356	0.039356	2.160257	Up	small nucleolar RNA, H/ACA box 11B	
CTAGE4	1.31302	0.038788	0.038788	2.16703	Up	CTAGE family member 4	
SNORA9	1.308653	0.027236	0.027236	2.328547	Up	small nucleolar RNA, H/ACA box 9	
APOB	1.29598	0.001043	0.001043	3.652911	Up	apolipoprotein B	
LCN12	1.258207	0.005394	0.005394	3.01344	Up	lipocalin 12	
MIR648	1.254627	0.042035	0.042035	2.129481	Up	microRNA 648	
SAPCD1	1.251793	0.000762	0.000762	3.771187	Up	suppressor APC domain containing 1	
RPL13AP5	1.217507	0.040849	0.040849	2.142888	Up	ribosomal protein L13a pseudogene 5	
TMEM52	1.213987	0.005725	0.005725	2.989444	Up	transmembrane protein 52	
LOC285095	1.202993	0.029569	0.029569	2.291487	Up	uncharacterized LOC285095	
PRICKLE4	1.154227	0.028453	0.028453	2.308873	Up	prickle planar cell polarity protein 4	
ADAD2	1.153307	0.006289	0.006289	2.951413	Up	adenosine deaminase domain containing 2	
TMEM145	1.111487	0.011906	0.011906	2.687862	Up	transmembrane protein 145	
C1orf185	1.084533	0.01231	0.01231	2.673805	Up	chromosome 1 open reading frame 185	
RORB	1.0637	0.008779	0.008779	2.814926	Up	RAR related orphan receptor B	
MIA	1.05382	0.049316	0.049316	2.053902	Up	MIA SH3 domain containing	
PGAM2	1.04492	0.021559	0.021559	2.432446	Up	phosphoglyceratemutase 2	
CECR2	1.02018	0.007304	0.007304	2.890514	Up	CECR2 histone acetyl-lysine reader	
BTNL8	1.017967	0.007634	0.007634	2.87239	Up	butyrophilin like 8	
UPK1A-AS1	1.01654	0.000323	0.000323	4.090921	Up	UPK1A antisense RNA 1	
WNT9B	1.010367	0.001141	0.001141	3.618927	Up	Wnt family member 9B	
ARL2-SNX15	0.99786	0.023389	0.023389	2.396471	Up	ARL2-SNX15 readthrough (NMD candidate)	
PNCK	0.997553	0.005518	0.005518	3.004258	Up	pregnancy up-regulated nonubiquitousCaM kinase	
DNM1P46	0.993367	0.014022	0.014022	2.618583	Up	dynamin 1 pseudogene 46	
SNORD116-2	0.993207	0.046271	0.046271	2.084217	Up	small nucleolar RNA, C/D box 116-2	
SNORA65	0.979973	0.041933	0.041933	2.13062	Up	small nucleolar RNA, H/ACA box 65	
NRXN1	0.9751	0.018721	0.018721	2.494208	Up	neurexin 1	
LINC01611	0.971233	0.014969	0.014969	2.590702	Up	long intergenic non-protein coding RNA 1611	
CFL1P1	0.965867	0.037627	0.037627	2.181137	Up	cofilin 1 pseudogene 1	
FAM27C	0.964833	0.013233	0.013233	2.643197	Up	family with sequence similarity 27 member C	
TPSD1	0.9607	0.026678	0.026678	2.337832	Up	tryptase delta 1	
STOX1	0.952087	0.00188	0.00188	3.427882	Up	storkhead box 1	
ARF4-AS1	0.948007	0.019319	0.019319	2.480515	Up	ARF4 antisense RNA 1	
PRPH	0.92522	0.002347	0.002347	3.342103	Up	peripherin	
FBXO10	0.923973	0.020523	0.020523	2.454076	Up	F-box protein 10	
PGM5P3-AS1	0.923733	0.027972	0.027972	2.316545	Up	PGM5P3 antisense RNA 1	
LRRC3-DT	0.920987	0.002375	0.002375	3.337439	Up	LRRC3 divergent transcript	
INO80B-WBP1	0.919893	0.002585	0.002585	3.304498	Up	INO80B-WBP1 readthrough (NMD candidate)	
SORD2P	0.91266	0.018154	0.018154	2.507572	Up	sorbitol dehydrogenase 2, pseudogene	
MYLPF	0.896867	0.035595	0.035595	2.206797	Up	myosin light chain, phosphorylatable, fast skeletal muscle	
LINC01999	0.894293	0.015657	0.015657	2.571441	Up	long intergenic non-protein coding RNA 1999	
CASQ2	0.890407	0.020198	0.020198	2.461069	Up	calsequestrin 2	
ULK4P1	0.887613	0.0333	0.0333	2.237399	Up	ULK4 pseudogene 1	
PLPP2	0.881447	0.019592	0.019592	2.474383	Up	phospholipid phosphatase 2	
CTD-3080P12.3	0.877473	0.011719	0.011719	2.694519	Up	uncharacterized LOC101928857	
KIF19	0.875667	0.021475	0.021475	2.434164	Up	kinesin family member 19	
KCNK7	0.871247	0.028119	0.028119	2.314193	Up	potassium two pore domain channel subfamily K member 7	
RASL10B	0.867707	0.004269	0.004269	3.107011	Up	RAS like family 10 member B	
NECAB1	0.860073	0.030586	0.030586	2.276158	Up	N-terminal EF-hand calcium binding protein 1	
LINC02055	0.854973	0.030277	0.030277	2.280768	Up	long intergenic non-protein coding RNA 2055	
PRODH	0.85302	0.024345	0.024345	2.378692	Up	proline dehydrogenase 1	
ZNF236-DT	0.852393	0.012753	0.012753	2.65886	Up	ZNF236 divergent transcript	
KCNE2	0.84654	0.007187	0.007187	2.897075	Up	potassium voltage-gated channel subfamily E regulatory subunit 2	
AZGP1	0.843307	0.003257	0.003257	3.214022	Up	alpha-2-glycoprotein 1, zinc-binding	
CSH1	0.833033	0.044542	0.044542	2.102229	Up	chorionic somatomammotropin hormone 1	
ALK	0.82582	0.000259	0.000259	4.172826	Up	ALK receptor tyrosine kinase	
CABP1	0.810267	0.030518	0.030518	2.277172	Up	calcium binding protein 1	
LOC101927533	0.80322	0.020402	0.020402	2.456678	Up	uncharacterized LOC101927533	
SRCIN1	0.794513	0.00297	0.00297	3.250227	Up	SRC kinase signaling inhibitor 1	
SOX2-OT	0.791187	0.046179	0.046179	2.085159	Up	SOX2 overlapping transcript	
SYCP2L	0.787927	0.042632	0.042632	2.122865	Up	synaptonemal complex protein 2 like	
IL17B	0.782547	0.046627	0.046627	2.080586	Up	interleukin 17B	
SZT2-AS1	0.777807	0.028194	0.028194	2.312991	Up	SZT2 antisense RNA 1	
DMKN	0.77704	0.033651	0.033651	2.232603	Up	dermokine	
FASN	0.770993	0.002809	0.002809	3.272056	Up	fatty acid synthase	
TAS2R9	0.762667	0.036931	0.036931	2.189782	Up	taste 2 receptor member 9	
ANKRD62	0.7576	0.002615	0.002615	3.299996	Up	ankyrin repeat domain 62	
LOC101927136	0.755833	0.002251	0.002251	3.358274	Up	uncharacterized LOC101927136	
ANKK1	0.753367	0.017117	0.017117	2.533042	Up	ankyrin repeat and kinase domain containing 1	
CFAP74	0.743753	0.005581	0.005581	2.999658	Up	cilia and flagella associated protein 74	
LYPD6	0.737533	0.00338	0.00338	3.199503	Up	LY6/PLAUR domain containing 6	
NAPA-AS1	0.735907	0.034244	0.034244	2.224594	Up	NAPA antisense RNA 1	
VWA3A	0.734973	0.041787	0.041787	2.132259	Up	von Willebrand factor A domain containing 3A	
PTPRQ	0.73148	0.016897	0.016897	2.538641	Up	protein tyrosine phosphatase receptor type Q	
MYOC	0.728007	0.016763	0.016763	2.542067	Up	myocilin	
ITIH1	0.724793	0.032609	0.032609	2.246995	Up	inter-alpha-trypsin inhibitor heavy chain 1	
HS3ST3A1	0.717073	0.025104	0.025104	2.365016	Up	heparansulfate-glucosamine 3-sulfotransferase 3A1	
LINC01933	0.716467	0.011121	0.011121	2.716498	Up	long intergenic non-protein coding RNA 1933	
CISH	0.70934	0.011846	0.011846	2.68998	Up	cytokine inducible SH2 containing protein	
PVALEF	0.708793	0.011966	0.011966	2.685743	Up	parvalbumin like EF-hand containing	
IL12A	0.7084	0.016266	0.016266	2.55505	Up	interleukin 12A	
ALPK3	0.707707	0.000804	0.000804	3.751428	Up	alpha kinase 3	
DLX1	0.704273	0.011251	0.011251	2.711629	Up	distal-less homeobox 1	
LOC105378909	0.692133	0.019505	0.019505	2.476342	Up	uncharacterized LOC105378909	
APOM	0.688733	0.02823	0.02823	2.312422	Up	apolipoprotein M	
PLIN5	0.68474	0.001495	0.001495	3.5159	Up	perilipin 5	
ALDH1L1-AS2	0.6837	0.021431	0.021431	2.435081	Up	ALDH1L1 antisense RNA 2	
LOC106660606	0.68294	0.003183	0.003183	3.223079	Up	uncharacterized LOC106660606	
NRL	0.672993	0.030217	0.030217	2.281668	Up	neural retina leucine zipper	
METTL14-DT	0.669567	0.029186	0.029186	2.29738	Up	METTL14 divergent transcript	
ASPRV1	0.660407	0.001149	0.001149	3.616304	Up	aspartic peptidase retroviral like 1	
LDB3	0.6577	0.009897	0.009897	2.765213	Up	LIM domain binding 3	
LINC02009	0.6576	0.008352	0.008352	2.835496	Up	long intergenic non-protein coding RNA 2009	
RGS3	0.657253	0.00054	0.00054	3.900444	Up	regulator of G protein signaling 3	
LOC100507144	0.656393	0.031232	0.031232	2.26667	Up	uncharacterized LOC100507144	
ANKRD23	0.6563	0.021153	0.021153	2.440814	Up	ankyrin repeat domain 23	
NAT14	0.656247	0.012995	0.012995	2.650898	Up	N-acetyltransferase 14 (putative)	
RAB26	0.650487	0.049246	0.049246	2.054576	Up	RAB26, member RAS oncogene family	
GLUL	0.645487	0.000796	0.000796	3.75498	Up	glutamate-ammonia ligase	
REEP2	0.6433	0.021322	0.021322	2.437319	Up	receptor accessory protein 2	
CACNB2	0.64148	0.022365	0.022365	2.416279	Up	calcium voltage-gated channel auxiliary subunit beta 2	
SLC2A4	0.64038	0.000861	0.000861	3.725632	Up	solute carrier family 2 member 4	
TMEM225B	0.639827	0.039209	0.039209	2.162007	Up	transmembrane protein 225B	
ADH1B	0.63968	0.001225	0.001225	3.592033	Up	alcohol dehydrogenase 1B (class I), beta polypeptide	
OR2A1	0.638853	0.034654	0.034654	2.219125	Up	olfactory receptor family 2 subfamily A member 1	
FAM166B	0.63752	0.040943	0.040943	2.141815	Up	family with sequence similarity 166 member B	
CPAMD8	0.636207	0.002923	0.002923	3.256463	Up	C3 and PZP like alpha-2-macroglobulin domain containing 8	
TMEM63C	0.63106	0.017919	0.017919	2.513237	Up	transmembrane protein 63C	
RPS10-NUDT3	0.630793	0.033586	0.033586	2.233482	Up	RPS10-NUDT3 readthrough	
GCK	0.630713	0.028465	0.028465	2.308684	Up	glucokinase	
PI4KAP1	0.62384	0.017826	0.017826	2.515496	Up	phosphatidylinositol 4-kinase alpha pseudogene 1	
TMEM31	0.62244	0.043782	0.043782	2.110345	Up	transmembrane protein 31	
CCDC116	0.617427	0.030932	0.030932	2.271057	Up	coiled-coil domain containing 116	
NIBAN3	0.616653	0.043308	0.043308	2.115469	Up	niban apoptosis regulator 3	
CCNA1	0.61624	0.001648	0.001648	3.478545	Up	cyclin A1	
FIRRE	0.611353	0.002658	0.002658	3.293698	Up	firreintergenic repeating RNA element	
IZUMO4	0.60368	0.000822	0.000822	3.74308	Up	IZUMO family member 4	
CLDN9	0.60176	0.002927	0.002927	3.255992	Up	claudin 9	
LINC02210	0.601	0.001418	0.001418	3.536152	Up	long intergenic non-protein coding RNA 2210	
CRHR1	0.6002	0.033417	0.033417	2.235799	Up	corticotropin releasing hormone receptor 1	
FBXO16	0.599627	0.03972	0.03972	2.155977	Up	F-box protein 16	
SHANK2	0.59854	0.014388	0.014388	2.607602	Up	SH3 and multiple ankyrin repeat domains 2	
SLIT1	0.596513	0.004491	0.004491	3.086835	Up	slit guidance ligand 1	
GLIS1	0.596373	0.043206	0.043206	2.11658	Up	GLIS family zinc finger 1	
ACPP	0.594933	0.00541	0.00541	3.01225	Up	acid phosphatase, prostate	
CKB	0.590053	0.004051	0.004051	3.127858	Up	creatine kinase B	
LINC02242	0.590047	0.011869	0.011869	2.689169	Up	long intergenic non-protein coding RNA 2242	
SLC25A52	0.585753	0.016106	0.016106	2.559307	Up	solute carrier family 25 member 52	
NR1I3	0.585567	0.008939	0.008939	2.807457	Up	nuclear receptor subfamily 1 group I member 3	
KCTD8	0.583867	0.010649	0.010649	2.734665	Up	potassium channel tetramerization domain containing 8	
CABP5	0.579207	0.016348	0.016348	2.552868	Up	calcium binding protein 5	
POMC	0.57794	0.043371	0.043371	2.114786	Up	proopiomelanocortin	
TMEM97	0.57492	0.002776	0.002776	3.276621	Up	transmembrane protein 97	
AATK	0.571247	0.027549	0.027549	2.323405	Up	apoptosis associated tyrosine kinase	
SLC16A13	0.57088	0.031188	0.031188	2.26731	Up	solute carrier family 16 member 13	
BCDIN3D-AS1	0.569787	0.039585	0.039585	2.157557	Up	BCDIN3D antisense RNA 1	
CACNA1A	0.569727	0.016613	0.016613	2.545947	Up	calcium voltage-gated channel subunit alpha1 A	
TCF15	0.56448	0.005889	0.005889	2.977994	Up	transcription factor 15	
CAPN11	0.55676	0.005395	0.005395	3.013368	Up	calpain 11	
ARHGEF26	0.556267	0.015335	0.015335	2.580344	Up	Rho guanine nucleotide exchange factor 26	
LINC01448	0.550493	0.036509	0.036509	2.19509	Up	long intergenic non-protein coding RNA 1448	
CEMP1	0.550073	0.037746	0.037746	2.179666	Up	cementum protein 1	
SLC4A4	0.54866	0.011569	0.011569	2.699917	Up	solute carrier family 4 member 4	
SLC26A7	0.545633	0.033131	0.033131	2.239734	Up	solute carrier family 26 member 7	
MAMDC4	0.54504	0.015232	0.015232	2.583254	Up	MAM domain containing 4	
CCNJL	0.541647	0.039394	0.039394	2.159812	Up	cyclin J like	
ADGRB3	0.53436	0.012864	0.012864	2.655173	Up	adhesion G protein-coupled receptor B3	
COQ8A	0.533247	2.73E-05	2.73E-05	4.994712	Up	coenzyme Q8A	
MYRF	0.53202	0.021212	0.021212	2.439579	Up	myelin regulatory factor	
GSN-AS1	0.53078	0.001542	0.001542	3.503971	Up	GSN antisense RNA 1	
SCN4A	0.52702	0.001219	0.001219	3.593912	Up	sodium voltage-gated channel alpha subunit 4	
TBILA	0.521813	0.027316	0.027316	2.327219	Up	TGF-beta induced lncRNA	
KCNE5	0.520333	0.029645	0.029645	2.290327	Up	potassium voltage-gated channel subfamily E regulatory subunit 5	
KIF26A	0.5177	0.005581	0.005581	2.999708	Up	kinesin family member 26A	
DNAJB13	0.517613	0.022862	0.022862	2.406568	Up	DnaJ heat shock protein family (Hsp40) member B13	
DDR1	0.517193	0.011322	0.011322	2.708988	Up	discoidin domain receptor tyrosine kinase 1	
MCM8-AS1	0.514307	0.033649	0.033649	2.232629	Up	MCM8 antisense RNA 1	
ZNF628	0.5143	0.045262	0.045262	2.09466	Up	zinc finger protein 628	
WDR62	0.514007	0.011393	0.011393	2.706387	Up	WD repeat domain 62	
LINC01252	0.513573	0.040364	0.040364	2.148465	Up	long intergenic non-protein coding RNA 1252	
WASHC1	0.50996	0.013544	0.013544	2.633328	Up	WASH complex subunit 1	
LOC101927322	0.509507	0.034309	0.034309	2.223715	Up	uncharacterized LOC101927322	
SRGAP2-AS1	0.50946	0.0068	0.0068	2.919675	Up	SRGAP2 antisense RNA 1	
GCAT	0.50868	0.01609	0.01609	2.559717	Up	glycine C-acetyltransferase	
LOC107984875	0.506533	0.00826	0.00826	2.840032	Up	uncharacterized LOC107984875	
LOC102723701	0.50454	0.013258	0.013258	2.6424	Up	uncharacterized LOC102723701	
FAM53A	0.503847	0.037478	0.037478	2.18297	Up	family with sequence similarity 53 member A	
CDKN2C	0.503407	0.039835	0.039835	2.154623	Up	cyclin dependent kinase inhibitor 2C	
LRRC56	0.50216	0.027171	0.027171	2.329615	Up	leucine rich repeat containing 56	
ZBTB49	0.4927	0.00058	0.00058	3.873677	Up	zinc finger and BTB domain containing 49	
SLC19A3	0.491447	0.006315	0.006315	2.949714	Up	solute carrier family 19 member 3	
SLED1	0.4908	0.030831	0.030831	2.272538	Up	proteoglycan 3, pro eosinophil major basic protein 2 pseudogene	
LINC01303	0.489687	0.049719	0.049719	2.05001	Up	long intergenic non-protein coding RNA 1303	
YJEFN3	0.48944	0.048569	0.048569	2.061184	Up	YjeF N-terminal domain containing 3	
SNTG2	0.48878	0.013005	0.013005	2.650565	Up	syntrophin gamma 2	
TMC2	0.488247	0.03642	0.03642	2.196216	Up	transmembrane channel like 2	
ESR2	0.487373	0.006741	0.006741	2.923214	Up	estrogen receptor 2	
MOCS1	0.486813	0.002197	0.002197	3.367734	Up	molybdenum cofactor synthesis 1	
RARRES1	0.486287	0.036546	0.036546	2.194625	Up	retinoic acid receptor responder 1	
SHROOM2	0.48562	0.018206	0.018206	2.506338	Up	shroom family member 2	
ISLR2	0.4846	0.025779	0.025779	2.353171	Up	immunoglobulin superfamily containing leucine rich repeat 2	
LDHD	0.484293	0.001457	0.001457	3.525893	Up	lactate dehydrogenase D	
NEK8	0.480767	0.012581	0.012581	2.664576	Up	NIMA related kinase 8	
CASKIN2	0.479527	0.002163	0.002163	3.373832	Up	CASK interacting protein 2	
DNAJC27-AS1	0.479133	0.022868	0.022868	2.406453	Up	DNAJC27 antisense RNA 1	
RRAD	0.476433	0.045177	0.045177	2.095545	Up	RRAD, Ras related glycolysis inhibitor and calcium channel regulator	
CYP2E1	0.47128	0.032339	0.032339	2.250786	Up	cytochrome P450 family 2 subfamily E member 1	
TEAD4	0.468247	0.017673	0.017673	2.519224	Up	TEA domain transcription factor 4	
DDX11	0.46768	0.048722	0.048722	2.059678	Up	DEAD/H-box helicase 11	
NACA4P	0.465847	0.043011	0.043011	2.118704	Up	NACA family member 4, pseudogene	
CLDN5	0.46164	0.026624	0.026624	2.338742	Up	claudin 5	
GNG7	0.45886	0.014547	0.014547	2.602925	Up	G protein subunit gamma 7	
KRT72	0.456787	0.041547	0.041547	2.134956	Up	keratin 72	
LINC02809	0.456087	0.006938	0.006938	2.911505	Up	long intergenic non-protein coding RNA 2809	
LHFPL5	0.45548	0.020195	0.020195	2.461145	Up	LHFPL tetraspan subfamily member 5	
SPTBN4	0.452893	0.002413	0.002413	3.331295	Up	spectrin beta, non-erythrocytic 4	
C2CD4C	0.4512	0.034423	0.034423	2.222197	Up	C2 calcium dependent domain containing 4C	
ADCK5	0.45064	0.001549	0.001549	3.502228	Up	aarF domain containing kinase 5	
DAPK2	0.44706	0.009496	0.009496	2.782402	Up	death associated protein kinase 2	
ZNF497	0.44476	0.045315	0.045315	2.094105	Up	zinc finger protein 497	
ACVR1C	0.44444	0.003862	0.003862	3.146791	Up	activin A receptor type 1C	
FOXI2	0.443987	0.032759	0.032759	2.2449	Up	forkhead box I2	
C20orf96	0.443067	0.041914	0.041914	2.130833	Up	chromosome 20 open reading frame 96	
SLC9A3R2	0.442747	0.029863	0.029863	2.287008	Up	SLC9A3 regulator 2	
KCTD16	0.438287	0.043244	0.043244	2.116163	Up	potassium channel tetramerization domain containing 16	
PTGDR	0.436873	0.015729	0.015729	2.569476	Up	prostaglandin D2 receptor	
SLC6A8	0.436447	0.002181	0.002181	3.37049	Up	solute carrier family 6 member 8	
C16orf95	0.435373	0.017815	0.017815	2.515764	Up	chromosome 16 open reading frame 95	
TGM2	0.43472	0.007717	0.007717	2.867995	Up	transglutaminase 2	
PFKFB3	0.433267	0.010683	0.010683	2.733323	Up	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	
FUT1	0.433133	0.009797	0.009797	2.769451	Up	fucosyltransferase 1 (H blood group)	
HDHD3	0.43204	0.001325	0.001325	3.561998	Up	haloaciddehalogenase like hydrolase domain containing 3	
SREBF1	0.4311	0.031848	0.031848	2.25777	Up	sterol regulatory element binding transcription factor 1	
MAP 2K4P1	0.431067	0.045905	0.045905	2.087978	Up	mitogen-activated protein kinase kinase 4 pseudogene 1	
SLC25A21-AS1	0.428013	0.013573	0.013573	2.632439	Up	SLC25A21 antisense RNA 1	
GCHFR	0.42692	0.035352	0.035352	2.209947	Up	GTP cyclohydrolase I feedback regulator	
MGARP	0.425933	0.017794	0.017794	2.516254	Up	mitochondria localized glutamic acid rich protein	
DLL1	0.425747	0.005394	0.005394	3.013381	Up	delta like canonical Notch ligand 1	
CCM2L	0.424847	0.000965	0.000965	3.682582	Up	CCM2 like scaffold protein	
NPC1L1	0.423333	0.027621	0.027621	2.322233	Up	NPC1 like intracellular cholesterol transporter 1	
SLC9A3R1	0.421333	0.011205	0.011205	2.713367	Up	SLC9A3 regulator 1	
ALDH1L1	0.419093	0.012238	0.012238	2.676261	Up	aldehyde dehydrogenase 1 family member L1	
SMIM10L2B	0.41812	0.028024	0.028024	2.315719	Up	small integral membrane protein 10 like 2B	
PLEKHG6	0.414233	0.027165	0.027165	2.329722	Up	pleckstrin homology and RhoGEF domain containing G6	
QRICH2	0.413027	0.034715	0.034715	2.218311	Up	glutamine rich 2	
DCXR	0.412747	0.007752	0.007752	2.866098	Up	dicarbonyl and L-xylulosereductase	
PKN3	0.41206	0.015873	0.015873	2.565566	Up	protein kinase N3	
LOC101929457	0.41076	0.010775	0.010775	2.729763	Up	uncharacterized LOC101929457	
MAP 3K5	0.410187	0.005026	0.005026	3.0418	Up	mitogen-activated protein kinase kinasekinase 5	
SHANK3	0.408153	0.029407	0.029407	2.293968	Up	SH3 and multiple ankyrin repeat domains 3	
FGFRL1	0.407573	0.00635	0.00635	2.947475	Up	fibroblast growth factor receptor like 1	
CROCCP2	0.406627	0.023876	0.023876	2.387337	Up	CROCC pseudogene 2	
LINC01840	0.405807	0.031576	0.031576	2.261679	Up	long intergenic non-protein coding RNA 1840	
SLFN13	0.405167	0.010758	0.010758	2.73039	Up	schlafen family member 13	
SLC30A3	0.40356	0.022155	0.022155	2.420441	Up	solute carrier family 30 member 3	
DOT1L	0.40182	0.002548	0.002548	3.310061	Up	DOT1 like histone lysine methyltransferase	
PWWP2B	0.40154	0.012178	0.012178	2.678326	Up	PWWP domain containing 2B	
PACSIN1	0.400867	0.013389	0.013389	2.63823	Up	protein kinase C and casein kinase substrate in neurons 1	
L3MBTL4	0.40056	0.013628	0.013628	2.630709	Up	L3MBTL histone methyl-lysine binding protein 4	
GALNT18	0.399947	0.03634	0.03634	2.197232	Up	polypeptide N-acetylgalactosaminyltransferase 18	
SCRN2	0.398233	0.005508	0.005508	3.005004	Up	secernin 2	
LIN7A	0.396253	0.001821	0.001821	3.440238	Up	lin-7 homolog A, crumbs cell polarity complex component	
TP73	0.396	0.010006	0.010006	2.760666	Up	tumor protein p73	
FAHD2B	0.395653	0.003867	0.003867	3.14628	Up	fumarylacetoacetate hydrolase domain containing 2B	
LINC01550	0.395573	0.02393	0.02393	2.386337	Up	long intergenic non-protein coding RNA 1550	
GS1-124K5.11	0.39448	0.002126	0.002126	3.380439	Up	RAB guanine nucleotide exchange factor 1 pseudogene	
KCTD17	0.39394	0.039791	0.039791	2.155139	Up	potassium channel tetramerization domain containing 17	
KLF15	0.393687	0.011645	0.011645	2.697181	Up	Kruppel like factor 15	
ATP2C2-AS1	0.391593	0.028443	0.028443	2.309025	Up	ATP2C2 antisense RNA 1	
SYT7	0.391587	0.043499	0.043499	2.113395	Up	synaptotagmin 7	
IRAK2	0.390753	0.038967	0.038967	2.164885	Up	interleukin 1 receptor associated kinase 2	
HELZ2	0.388267	0.036382	0.036382	2.196698	Up	helicase with zinc finger 2	
MLXIPL	0.386427	0.010972	0.010972	2.722173	Up	MLX interacting protein like	
GINS3	0.386213	0.018589	0.018589	2.4973	Up	GINS complex subunit 3	
EGFLAM	0.385367	0.018454	0.018454	2.500454	Up	EGF like, fibronectin type III and laminin G domains	
CASC16	0.384113	0.03905	0.03905	2.163893	Up	cancer susceptibility 16	
BOK	0.382033	0.00183	0.00183	3.438406	Up	BCL2 family apoptosis regulator BOK	
ADCY4	0.380647	0.007812	0.007812	2.862943	Up	adenylatecyclase 4	
SPHK1	0.378633	0.043493	0.043493	2.113465	Up	sphingosine kinase 1	
PPP1R16A	0.378367	0.041909	0.041909	2.130896	Up	protein phosphatase 1 regulatory subunit 16A	
HOMEZ	0.3768	0.003024	0.003024	3.243199	Up	homeobox and leucine zipper encoding	
TAF1C	0.375107	0.020069	0.020069	2.463884	Up	TATA-box binding protein associated factor, RNA polymerase I subunit C	
PDCD2L	0.373413	0.005258	0.005258	3.023712	Up	programmed cell death 2 like	
DEPP1	0.36932	0.043836	0.043836	2.109767	Up	DEPP1 autophagy regulator	
CDK20	0.369047	0.040925	0.040925	2.142014	Up	cyclin dependent kinase 20	
KIFC2	0.36856	0.011059	0.011059	2.718839	Up	kinesin family member C2	
LOC101927495	0.36686	0.042416	0.042416	2.125249	Up	uncharacterized LOC101927495	
MED16	0.3667	0.031179	0.031179	2.26744	Up	mediator complex subunit 16	
PRCD	0.365607	0.008088	0.008088	2.848706	Up	photoreceptor disc component	
CD320	0.365453	0.014275	0.014275	2.610964	Up	CD320 molecule	
LLGL2	0.365393	0.034201	0.034201	2.225165	Up	LLGL scribble cell polarity complex component 2	
ECHDC3	0.36472	0.023262	0.023262	2.398894	Up	enoyl-CoA hydratase domain containing 3	
GK	0.364333	0.039685	0.039685	2.156382	Up	glycerol kinase	
MARCHF3	0.361713	0.022439	0.022439	2.414818	Up	membrane associated ring-CH-type finger 3	
GRASP	0.359927	0.014748	0.014748	2.597057	Up	general receptor for phosphoinositides 1 associated scaffold protein	
NBPF10	0.359027	0.017461	0.017461	2.524435	Up	NBPF member 10	
SLC25A22	0.358167	0.028361	0.028361	2.310329	Up	solute carrier family 25 member 22	
FRMD1	0.355467	0.014648	0.014648	2.599955	Up	FERM domain containing 1	
GNG3	0.35502	0.041873	0.041873	2.131292	Up	G protein subunit gamma 3	
PTPN3	0.35484	0.017609	0.017609	2.520785	Up	protein tyrosine phosphatase non-receptor type 3	
ZNF775	0.354047	0.010894	0.010894	2.725137	Up	zinc finger protein 775	
CEBPD	0.35346	0.032804	0.032804	2.244272	Up	CCAAT enhancer binding protein delta	
EDA	0.353147	0.026661	0.026661	2.338123	Up	ectodysplasin A	
CPLX1	0.353027	0.046099	0.046099	2.085981	Up	complexin 1	
SLC35G2	0.352027	0.003293	0.003293	3.209745	Up	solute carrier family 35 member G2	
LGALS12	0.351687	0.025859	0.025859	2.351799	Up	galectin 12	
CNTFR	0.350407	0.039045	0.039045	2.163954	Up	ciliaryneurotrophic factor receptor	
KANK3	0.349893	0.030518	0.030518	2.277178	Up	KN motif and ankyrin repeat domains 3	
TPRN	0.349767	0.01286	0.01286	2.655322	Up	taperin	
INAFM1	0.349327	0.033182	0.033182	2.239034	Up	InaF motif containing 1	
SLC2A11	0.349233	0.003274	0.003274	3.212037	Up	solute carrier family 2 member 11	
ZNF784	0.349	0.01501	0.01501	2.589523	Up	zinc finger protein 784	
MKNK2	0.348927	0.004343	0.004343	3.100189	Up	MAPK interacting serine/threonine kinase 2	
UBTD1	0.348413	0.022659	0.022659	2.4105	Up	ubiquitin domain containing 1	
NBR2	0.348333	0.035792	0.035792	2.204241	Up	neighbor of BRCA1 lncRNA 2	
POLM	0.34684	0.013365	0.013365	2.638976	Up	DNA polymerase mu	
GPIHBP1	0.346247	0.025151	0.025151	2.364191	Up	glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1	
GLYCTK	0.345573	0.037605	0.037605	2.181401	Up	glycerate kinase	
LINC01179	0.345427	0.007842	0.007842	2.861379	Up	long intergenic non-protein coding RNA 1179	
GPT2	0.345107	0.005711	0.005711	2.990416	Up	glutamic--pyruvic transaminase 2	
RABL2B	0.344613	0.008317	0.008317	2.837186	Up	RAB, member of RAS oncogene family like 2B	
MIB2	0.343647	0.016939	0.016939	2.537552	Up	mindbomb E3 ubiquitin protein ligase 2	
TNFRSF8	0.342827	0.028406	0.028406	2.309619	Up	TNF receptor superfamily member 8	
EPB41L4B	0.341027	0.049728	0.049728	2.049921	Up	erythrocyte membrane protein band 4.1 like 4B	
CENPX	0.34044	0.004819	0.004819	3.058676	Up	centromere protein X	
PXMP2	0.338413	0.021778	0.021778	2.427992	Up	peroxisomal membrane protein 2	
CA4	0.33818	0.025048	0.025048	2.366019	Up	carbonic anhydrase 4	
RDH13	0.337287	0.016751	0.016751	2.54239	Up	retinol dehydrogenase 13	
WNT11	0.337087	0.024224	0.024224	2.380901	Up	Wnt family member 11	
ZNF727	0.336547	0.02561	0.02561	2.356123	Up	zinc finger protein 727	
TMEM143	0.335967	0.032586	0.032586	2.247312	Up	transmembrane protein 143	
WDR90	0.333773	0.023394	0.023394	2.39637	Up	WD repeat domain 90	
CARD10	0.331487	0.026367	0.026367	2.343088	Up	caspase recruitment domain family member 10	
CCDC88C	0.329653	0.00813	0.00813	2.846562	Up	coiled-coil domain containing 88C	
GPHN	0.32896	0.003334	0.003334	3.204898	Up	gephyrin	
CASP16P	0.328467	0.039239	0.039239	2.161647	Up	caspase 16, pseudogene	
ADIRF	0.32752	0.000578	0.000578	3.874897	Up	adipogenesis regulatory factor	
PCDHGC4	0.32742	0.037028	0.037028	2.188563	Up	protocadherin gamma subfamily C, 4	
KIAA0895L	0.327093	0.005065	0.005065	3.038666	Up	KIAA0895 like	
ACSS2	0.325927	0.000183	0.000183	4.301369	Up	acyl-CoA synthetase short chain family member 2	
LOC100996842	0.325027	0.042419	0.042419	2.125216	Up	uncharacterized LOC100996842	
ZNF366	0.324253	0.0029	0.0029	3.25961	Up	zinc finger protein 366	
EBP	0.321927	0.011617	0.011617	2.698192	Up	EBP cholestenol delta-isomerase	
BSN	0.32112	0.02936	0.02936	2.294702	Up	bassoon presynaptic cytomatrix protein	
DHRS3	0.319227	0.003256	0.003256	3.214186	Up	dehydrogenase/reductase 3	
OPLAH	0.317693	0.008179	0.008179	2.844112	Up	5-oxoprolinase, ATP-hydrolysing	
SETD1A	0.3171	0.035833	0.035833	2.203722	Up	SET domain containing 1A, histone lysine methyltransferase	
TYSND1	0.31578	0.007605	0.007605	2.873964	Up	trypsin domain containing 1	
TRMT1L	0.314633	0.010321	0.010321	2.74775	Up	tRNAmethyltransferase 1 like	
EDNRA	0.311733	0.049481	0.049481	2.052308	Up	endothelin receptor type A	
TDRKH	0.31074	0.028108	0.028108	2.314361	Up	tudor and KH domain containing	
EXD3	0.310607	0.040952	0.040952	2.14171	Up	exonuclease 3'-5' domain containing 3	
PEAR1	0.308427	0.037173	0.037173	2.186759	Up	platelet endothelial aggregation receptor 1	
LMLN	0.30822	0.010311	0.010311	2.748134	Up	leishmanolysin like peptidase	
AASS	0.308027	0.039253	0.039253	2.161477	Up	aminoadipate-semialdehyde synthase	
LRRC29	0.308	0.040371	0.040371	2.148389	Up	leucine rich repeat containing 29	
EIF1B-AS1	0.307667	0.014918	0.014918	2.592162	Up	EIF1B antisense RNA 1	
MPND	0.307367	0.01476	0.01476	2.596721	Up	MPN domain containing	
SPHK2	0.30734	0.045158	0.045158	2.095746	Up	sphingosine kinase 2	
VPS37B	0.306187	0.009521	0.009521	2.781321	Up	VPS37B subunit of ESCRT-I	
ZNF821	0.304933	0.029371	0.029371	2.294531	Up	zinc finger protein 821	
EPHB4	0.304347	0.016088	0.016088	2.559768	Up	EPH receptor B4	
MICALL1	0.30348	0.029928	0.029928	2.286026	Up	MICAL like 1	
CENPS	0.303127	0.00445	0.00445	3.090472	Up	centromere protein S	
RAC3	0.302293	0.024619	0.024619	2.373715	Up	Rac family small GTPase 3	
SAG	0.302187	0.043818	0.043818	2.109961	Up	S-antigen visual arrestin	
ADHFE1	0.301933	0.013006	0.013006	2.650532	Up	alcohol dehydrogenase iron containing 1	
LINC01460	0.301607	0.014749	0.014749	2.597019	Up	long intergenic non-protein coding RNA 1460	
ACAT2	0.301127	0.049893	0.049893	2.048342	Up	acetyl-CoA acetyltransferase 2	
USHBP1	0.300987	0.010881	0.010881	2.725632	Up	USH1 protein network component harmonin binding protein 1	
RAPGEF3	0.300947	0.02845	0.02845	2.308918	Up	Rap guanine nucleotide exchange factor 3	
EP400P1	0.300847	0.035764	0.035764	2.204603	Up	EP400 pseudogene 1	
CSPG4	0.3001	0.005719	0.005719	2.98983	Up	chondroitin sulfate proteoglycan 4	
TMEM53	0.29854	0.020161	0.020161	2.461868	Up	transmembrane protein 53	
PMM1	0.297573	0.014532	0.014532	2.603367	Up	phosphomannomutase 1	
ARHGEF15	0.29746	0.049419	0.049419	2.052904	Up	Rho guanine nucleotide exchange factor 15	
CD3EAP	0.296887	0.037923	0.037923	2.177497	Up	CD3e molecule associated protein	
IMPA2	0.296727	0.033772	0.033772	2.230953	Up	inositol monophosphatase 2	
PUSL1	0.296007	0.036908	0.036908	2.190066	Up	pseudouridine synthase like 1	
MRPL11	0.29498	0.003492	0.003492	3.186591	Up	mitochondrial ribosomal protein L11	
RRP1	0.294953	0.013034	0.013034	2.649615	Up	ribosomal RNA processing 1	
C19orf25	0.294907	0.024903	0.024903	2.368605	Up	chromosome 19 open reading frame 25	
LINC01128	0.294653	0.028588	0.028588	2.306742	Up	long intergenic non-protein coding RNA 1128	
PSEN2	0.292733	0.016252	0.016252	2.555403	Up	presenilin 2	
MVD	0.29174	0.049805	0.049805	2.049181	Up	mevalonatediphosphate decarboxylase	
FLJ31104	0.29174	0.041537	0.041537	2.135077	Up	uncharacterized LOC441072	
IRX6	0.287387	0.049491	0.049491	2.05221	Up	iroquoishomeobox 6	
GGT6	0.285007	0.03879	0.03879	2.167003	Up	gamma-glutamyltransferase 6	
HOXA6	0.284887	0.036879	0.036879	2.190424	Up	homeobox A6	
SLC25A10	0.28452	0.046013	0.046013	2.086869	Up	solute carrier family 25 member 10	
TBC1D7	0.284187	0.014585	0.014585	2.601801	Up	TBC1 domain family member 7	
GPR146	0.283147	0.009124	0.009124	2.798966	Up	G protein-coupled receptor 146	
LOC648987	0.282687	0.014648	0.014648	2.599972	Up	uncharacterized LOC648987	
RASIP1	0.28128	0.025608	0.025608	2.356149	Up	Ras interacting protein 1	
THAP3	0.28086	0.005152	0.005152	3.031874	Up	THAP domain containing 3	
SH3D21	0.279873	0.047297	0.047297	2.073815	Up	SH3 domain containing 21	
ZNF598	0.279487	0.036933	0.036933	2.189749	Up	zinc finger protein 598	
VAMP2	0.278927	0.036654	0.036654	2.193255	Up	vesicle associated membrane protein 2	
FAM131A	0.277193	0.01078	0.01078	2.729571	Up	family with sequence similarity 131 member A	
PLEKHH3	0.276973	0.021042	0.021042	2.443126	Up	pleckstrin homology, MyTH4 and FERM domain containing H3	
MPST	0.27696	0.044439	0.044439	2.103324	Up	mercaptopyruvatesulfurtransferase	
EGFL7	0.27696	0.043764	0.043764	2.110539	Up	EGF like domain multiple 7	
NFKBIL1	0.27696	0.02297	0.02297	2.404471	Up	NFKB inhibitor like 1	
STBD1	0.274827	0.021907	0.021907	2.425394	Up	starch binding domain 1	
SMIM10L2A	0.274493	0.0499	0.0499	2.048272	Up	small integral membrane protein 10 like 2A	
SNHG20	0.274367	0.023088	0.023088	2.402207	Up	small nucleolar RNA host gene 20	
ARSG	0.27384	0.042052	0.042052	2.1293	Up	arylsulfatase G	
DANCR	0.272867	0.039453	0.039453	2.159115	Up	differentiation antagonizing non-protein coding RNA	
TNS2	0.27146	0.021422	0.021422	2.435265	Up	tensin 2	
SVOP	0.270813	0.040165	0.040165	2.150772	Up	SV2 related protein	
TAB1	0.269447	0.04564	0.04564	2.090719	Up	TGF-beta activated kinase 1 (MAP 3K7) binding protein 1	
SEMA4C	0.26936	0.012182	0.012182	2.678211	Up	semaphorin 4C	
HADH	0.267253	0.017346	0.017346	2.527301	Up	hydroxyacyl-CoA dehydrogenase	
USH2A	0.26662	0.002348	0.002348	3.34197	Up	usherin	
ACADS	0.266613	0.026468	0.026468	2.341366	Up	acyl-CoA dehydrogenase short chain	
HLA-F	0.266587	0.026586	0.026586	2.339375	Up	major histocompatibility complex, class I, F	
MAIP1	0.26484	0.025931	0.025931	2.350542	Up	matrix AAA peptidase interacting protein 1	
PCBD2	0.264567	0.010857	0.010857	2.726568	Up	pterin-4 alpha-carbinolaminedehydratase 2	
IFI35	0.263513	0.04722	0.04722	2.074586	Up	interferon induced protein 35	
POU6F1	0.261913	0.0477	0.0477	2.069781	Up	POU class 6 homeobox 1	
GUCD1	0.261527	0.018894	0.018894	2.490219	Up	guanylylcyclase domain containing 1	
FAHD2CP	0.260187	0.010239	0.010239	2.751057	Up	fumarylacetoacetate hydrolase domain containing 2C, pseudogene	
AP1M2	-1.83963	0.000873	0.000873	-3.7202	Down	adaptor related protein complex 1 subunit mu 2	
KRT16	-1.66819	0.001376	0.001376	-3.54761	Down	keratin 16	
TMED7-TICAM2	-1.46751	0.03117	0.03117	-2.26757	Down	TMED7-TICAM2 readthrough	
SLIT2-IT1	-1.40593	0.003861	0.003861	-3.1469	Down	SLIT2 intronic transcript 1	
UBD	-1.39199	0.034472	0.034472	-2.22154	Down	ubiquitin D	
GTF2A1L	-1.34071	0.036078	0.036078	-2.20057	Down	general transcription factor IIA subunit 1 like	
SYCE3	-1.27163	0.001032	0.001032	-3.65703	Down	synaptonemal complex central element protein 3	
TUBB2B	-1.23847	0.010346	0.010346	-2.74672	Down	tubulin beta 2B class IIb	
LINC01315	-1.17362	0.005379	0.005379	-3.01454	Down	long intergenic non-protein coding RNA 1315	
LINC02541	-1.17343	0.015393	0.015393	-2.57875	Down	long intergenic non-protein coding RNA 2541	
VEPH1	-1.17286	0.002124	0.002124	-3.38071	Down	ventricular zone expressed PH domain containing 1	
NDST1-AS1	-1.14183	0.036221	0.036221	-2.19875	Down	NDST1 antisense RNA 1	
LINC01876	-1.12505	0.009476	0.009476	-2.78327	Down	long intergenic non-protein coding RNA 1876	
LOC101928228	-1.11811	0.002831	0.002831	-3.26903	Down	uncharacterized LOC101928228	
ARL5C	-1.10639	0.017561	0.017561	-2.52198	Down	ADP ribosylation factor like GTPase 5C	
DYNLRB2	-1.08251	0.024003	0.024003	-2.38498	Down	dynein light chain roadblock-type 2	
H1-1	-1.06444	0.020425	0.020425	-2.45617	Down	H1.1 linker histone, cluster member	
AADACL3	-1.06131	0.001719	0.001719	-3.46237	Down	arylacetamidedeacetylase like 3	
NPIPB8	-1.04889	0.026769	0.026769	-2.33631	Down	nuclear pore complex interacting protein family member B8	
LINC01909	-1.04454	0.015374	0.015374	-2.57927	Down	long intergenic non-protein coding RNA 1909	
CCL18	-1.03957	0.012174	0.012174	-2.67847	Down	C-C motif chemokine ligand 18	
SFRP2	-1.03733	0.010127	0.010127	-2.75565	Down	secreted frizzled related protein 2	
LINC00861	-1.03042	0.005653	0.005653	-2.9945	Down	long intergenic non-protein coding RNA 861	
PLEK2	-1.01229	0.006901	0.006901	-2.91366	Down	pleckstrin 2	
CFAP61	-1.01106	0.033284	0.033284	-2.23762	Down	cilia and flagella associated protein 61	
HPGDS	-0.9886	0.000699	0.000699	-3.80361	Down	hematopoietic prostaglandin D synthase	
KRT14	-0.97832	0.003559	0.003559	-3.17915	Down	keratin 14	
SERF1A	-0.97264	0.031251	0.031251	-2.26638	Down	small EDRK-rich factor 1A	
LINC02621	-0.96818	0.010579	0.010579	-2.73741	Down	long intergenic non-protein coding RNA 2621	
KCNA1	-0.95145	0.003218	0.003218	-3.21883	Down	potassium voltage-gated channel subfamily A member 1	
ANKRD1	-0.94966	0.020504	0.020504	-2.45449	Down	ankyrin repeat domain 1	
UBE2QL1	-0.94181	0.002868	0.002868	-3.26387	Down	ubiquitin conjugating enzyme E2 Q family like 1	
C15orf65	-0.93809	0.010552	0.010552	-2.73851	Down	chromosome 15 open reading frame 65	
OLAH	-0.93508	0.010115	0.010115	-2.75615	Down	oleoyl-ACP hydrolase	
ARHGEF9-IT1	-0.92943	0.032287	0.032287	-2.25152	Down	ARHGEF9 intronic transcript 1	
KCNA2	-0.92134	0.004863	0.004863	-3.05502	Down	potassium voltage-gated channel subfamily A member 2	
MXRA5	-0.91562	0.000951	0.000951	-3.68797	Down	matrix remodeling associated 5	
JPH2	-0.91528	0.000873	0.000873	-3.72019	Down	junctophilin 2	
C17orf99	-0.91307	0.022929	0.022929	-2.40527	Down	chromosome 17 open reading frame 99	
PROSER2-AS1	-0.90959	0.000174	0.000174	-4.31999	Down	PROSER2 antisense RNA 1	
FYB2	-0.90903	0.022109	0.022109	-2.42135	Down	FYN binding protein 2	
PTPRZ1	-0.89926	0.026794	0.026794	-2.33589	Down	protein tyrosine phosphatase receptor type Z1	
ITGB1BP2	-0.89303	0.015913	0.015913	-2.56447	Down	integrin subunit beta 1 binding protein 2	
ZFHX4-AS1	-0.88985	0.034802	0.034802	-2.21716	Down	ZFHX4 antisense RNA 1	
LOC100505622	-0.88851	0.026329	0.026329	-2.34373	Down	uncharacterized LOC100505622	
LOC107986163	-0.8756	0.037842	0.037842	-2.17849	Down	uncharacterized LOC107986163	
GABRB2	-0.87298	0.014162	0.014162	-2.61436	Down	gamma-aminobutyric acid type A receptor beta2 subunit	
CELF4	-0.8686	0.024073	0.024073	-2.38368	Down	CUGBP Elav-like family member 4	
C4BPB	-0.86515	0.026739	0.026739	-2.33681	Down	complement component 4 binding protein beta	
ATRNL1	-0.86285	0.004747	0.004747	-3.06464	Down	attractin like 1	
INHBA	-0.85583	0.003642	0.003642	-3.16997	Down	inhibin subunit beta A	
LINC00323	-0.85416	0.021827	0.021827	-2.42701	Down	long intergenic non-protein coding RNA 323	
FAM151A	-0.85212	0.042001	0.042001	-2.12987	Down	family with sequence similarity 151 member A	
STKLD1	-0.85192	0.01049	0.01049	-2.74094	Down	serine/threonine kinase like domain containing 1	
NMRAL2P	-0.85008	0.038159	0.038159	-2.17462	Down	NmrA like redox sensor 2, pseudogene	
MYBPHL	-0.84666	0.001678	0.001678	-3.47163	Down	myosin binding protein H like	
GRM5	-0.84575	0.001062	0.001062	-3.64624	Down	glutamate metabotropic receptor 5	
LBP	-0.84142	0.003065	0.003065	-3.23785	Down	lipopolysaccharide binding protein	
SEZ6	-0.83764	0.01322	0.01322	-2.64362	Down	seizure related 6 homolog	
CACNG2	-0.82779	0.003396	0.003396	-3.19763	Down	calcium voltage-gated channel auxiliary subunit gamma 2	
OLR1	-0.82579	0.044364	0.044364	-2.10412	Down	oxidized low density lipoprotein receptor 1	
CHST4	-0.81618	0.005129	0.005129	-3.03367	Down	carbohydrate sulfotransferase 4	
SERPINE1	-0.8149	0.023386	0.023386	-2.39654	Down	serpin family E member 1	
ACSM1	-0.81072	0.006117	0.006117	-2.96266	Down	acyl-CoA synthetase medium chain family member 1	
BPI	-0.80597	0.019588	0.019588	-2.47448	Down	bactericidal permeability increasing protein	
ANGPT2	-0.80309	0.000141	0.000141	-4.3973	Down	angiopoietin 2	
HLA-DQA1	-0.79472	0.007581	0.007581	-2.87525	Down	major histocompatibility complex, class II, DQ alpha 1	
LOC105371050	-0.79405	0.025335	0.025335	-2.36094	Down	uncharacterized LOC105371050	
KBTBD12	-0.77889	0.013931	0.013931	-2.62137	Down	kelch repeat and BTB domain containing 12	
VSTM2L	-0.77399	0.040074	0.040074	-2.15183	Down	V-set and transmembrane domain containing 2 like	
PDPN	-0.77141	0.022771	0.022771	-2.40832	Down	podoplanin	
SPESP1	-0.76823	0.018515	0.018515	-2.49903	Down	sperm equatorial segment protein 1	
EPHX4	-0.76699	0.000847	0.000847	-3.73178	Down	epoxide hydrolase 4	
LINC01366	-0.76575	0.020048	0.020048	-2.46434	Down	long intergenic non-protein coding RNA 1366	
RAMP1	-0.75425	0.03836	0.03836	-2.17218	Down	receptor activity modifying protein 1	
APLN	-0.75123	0.035932	0.035932	-2.20245	Down	apelin	
BCYRN1	-0.75046	0.0142	0.0142	-2.61323	Down	brain cytoplasmic RNA 1	
PROM1	-0.74233	0.016077	0.016077	-2.56008	Down	prominin 1	
EMBP1	-0.74181	0.006074	0.006074	-2.9655	Down	embiginpseudogene 1	
EPHB3	-0.73908	0.006539	0.006539	-2.93556	Down	EPH receptor B3	
ASAH2	-0.73624	0.008099	0.008099	-2.84812	Down	N-acylsphingosineamidohydrolase 2	
TMLHE-AS1	-0.73541	0.03531	0.03531	-2.21049	Down	TMLHE antisense RNA 1	
NUGGC	-0.73261	0.001609	0.001609	-3.4879	Down	nuclear GTPase, germinal center associated	
LOC112268408	-0.73205	0.047435	0.047435	-2.07242	Down	uncharacterized LOC112268408	
SCOC-AS1	-0.73056	0.029921	0.029921	-2.28613	Down	SCOC antisense RNA 1	
CYTL1	-0.72915	0.046418	0.046418	-2.08271	Down	cytokine like 1	
LINC01861	-0.72737	0.005976	0.005976	-2.97207	Down	long intergenic non-protein coding RNA 1861	
DRD1	-0.71583	0.006026	0.006026	-2.96871	Down	dopamine receptor D1	
DDX43	-0.71493	0.029747	0.029747	-2.28877	Down	DEAD-box helicase 43	
LINGO1	-0.71183	0.004311	0.004311	-3.10312	Down	leucine rich repeat and Ig domain containing 1	
HSD11B1	-0.70994	0.009219	0.009219	-2.7947	Down	hydroxysteroid 11-beta dehydrogenase 1	
SRPX2	-0.70059	0.000163	0.000163	-4.34405	Down	sushi repeat containing protein X-linked 2	
TNMD	-0.69969	0.002375	0.002375	-3.33749	Down	tenomodulin	
CYP2C9	-0.69773	0.038159	0.038159	-2.17462	Down	cytochrome P450 family 2 subfamily C member 9	
MFAP5	-0.69703	0.002943	0.002943	-3.25378	Down	microfibril associated protein 5	
LINC00449	-0.69067	0.032549	0.032549	-2.24783	Down	long intergenic non-protein coding RNA 449	
PAGE4	-0.67675	0.02332	0.02332	-2.39778	Down	PAGE family member 4	
LINC02688	-0.67659	0.040433	0.040433	-2.14768	Down	long intergenic non-protein coding RNA 2688	
LINC02384	-0.67644	0.01088	0.01088	-2.72568	Down	long intergenic non-protein coding RNA 2384	
KRT5	-0.66945	0.020488	0.020488	-2.45483	Down	keratin 5	
PLA2G2C	-0.66438	0.021408	0.021408	-2.43554	Down	phospholipase A2 group IIC	
SLC47A1	-0.66283	0.004917	0.004917	-3.05058	Down	solute carrier family 47 member 1	
KRTAP5-8	-0.66176	0.013759	0.013759	-2.62665	Down	keratin associated protein 5-8	
FASLG	-0.65842	0.024609	0.024609	-2.37389	Down	Fas ligand	
LINC01088	-0.6579	0.007562	0.007562	-2.87629	Down	long intergenic non-protein coding RNA 1088	
HMGA2-AS1	-0.65634	0.027717	0.027717	-2.32068	Down	HMGA2 antisense RNA 1	
TNFRSF12A	-0.64562	0.036314	0.036314	-2.19757	Down	TNF receptor superfamily member 12A	
CCDC122	-0.64133	0.026547	0.026547	-2.34004	Down	coiled-coil domain containing 122	
PSAT1	-0.63545	0.001949	0.001949	-3.41395	Down	phosphoserine aminotransferase 1	
F13A1	-0.63391	0.006252	0.006252	-2.95381	Down	coagulation factor XIII A chain	
DHH	-0.63179	0.021762	0.021762	-2.42833	Down	desert hedgehog signaling molecule	
RERG	-0.63159	0.001024	0.001024	-3.65989	Down	RAS like estrogen regulated growth inhibitor	
BLOC1S5-TXNDC5	-0.6295	0.027925	0.027925	-2.3173	Down	BLOC1S5-TXNDC5 readthrough (NMD candidate)	
LOC101927708	-0.62838	0.031922	0.031922	-2.25671	Down	uncharacterized LOC101927708	
SLC4A3	-0.62674	0.017538	0.017538	-2.52255	Down	solute carrier family 4 member 3	
FLNC	-0.62642	0.020204	0.020204	-2.46095	Down	filamin C	
AMPD1	-0.62482	0.047649	0.047649	-2.07029	Down	adenosine monophosphate deaminase 1	
SLIT2	-0.624	0.001565	0.001565	-3.49831	Down	slit guidance ligand 2	
LYVE1	-0.62117	0.010171	0.010171	-2.75382	Down	lymphatic vessel endothelial hyaluronan receptor 1	
C16orf71	-0.61966	0.032589	0.032589	-2.24728	Down	chromosome 16 open reading frame 71	
HFM1	-0.6184	0.01019	0.01019	-2.75307	Down	helicase for meiosis 1	
FRZB	-0.6172	0.043793	0.043793	-2.11023	Down	frizzled related protein	
ANKRD44-IT1	-0.61691	0.019758	0.019758	-2.47071	Down	ANKRD44 intronic transcript 1	
IQCH	-0.61355	0.024461	0.024461	-2.37658	Down	IQ motif containing H	
HSD17B2	-0.61154	0.0392	0.0392	-2.16211	Down	hydroxysteroid 17-beta dehydrogenase 2	
HTR7	-0.61001	0.020491	0.020491	-2.45477	Down	5-hydroxytryptamine receptor 7	
TIGIT	-0.60797	0.038413	0.038413	-2.17154	Down	T cell immunoreceptor with Ig and ITIM domains	
CD28	-0.60719	0.005482	0.005482	-3.00687	Down	CD28 molecule	
RFX4	-0.60674	0.023241	0.023241	-2.39928	Down	regulatory factor X4	
LRRTM2	-0.60411	0.016618	0.016618	-2.54583	Down	leucine rich repeat transmembrane neuronal 2	
THBS1	-0.60387	0.012722	0.012722	-2.65989	Down	thrombospondin 1	
LINC01376	-0.6004	0.01737	0.01737	-2.5267	Down	long intergenic non-protein coding RNA 1376	
FCGR1B	-0.59985	0.037964	0.037964	-2.177	Down	Fc fragment of IgG receptor Ib	
ADAMTS6	-0.59864	0.002691	0.002691	-3.28887	Down	ADAM metallopeptidase with thrombospondin type 1 motif 6	
SLC6A1	-0.59683	0.019212	0.019212	-2.48293	Down	solute carrier family 6 member 1	
NEK10	-0.59117	0.0202	0.0202	-2.46102	Down	NIMA related kinase 10	
SYT12	-0.59044	0.010636	0.010636	-2.73517	Down	synaptotagmin 12	
THBS2	-0.58761	0.000849	0.000849	-3.73069	Down	thrombospondin 2	
PEMT	-0.58693	0.042542	0.042542	-2.12385	Down	phosphatidylethanolamine N-methyltransferase	
CLEC4M	-0.58663	0.001339	0.001339	-3.55795	Down	C-type lectin domain family 4 member M	
HTR2B	-0.58465	0.012081	0.012081	-2.68169	Down	5-hydroxytryptamine receptor 2B	
DUXAP8	-0.58371	0.037364	0.037364	-2.18438	Down	double homeobox A pseudogene 8	
DAO	-0.58274	0.015121	0.015121	-2.58637	Down	D-amino acid oxidase	
ZNF208	-0.57918	0.007614	0.007614	-2.87346	Down	zinc finger protein 208	
ODF3L1	-0.57736	0.013767	0.013767	-2.62641	Down	outer dense fiber of sperm tails 3 like 1	
TFAP2C	-0.57669	0.03794	0.03794	-2.17729	Down	transcription factor AP-2 gamma	
TNF	-0.57654	0.037316	0.037316	-2.18498	Down	tumor necrosis factor	
GRB14	-0.57595	0.037375	0.037375	-2.18424	Down	growth factor receptor bound protein 14	
FAP	-0.57409	0.016017	0.016017	-2.56167	Down	fibroblast activation protein alpha	
ZBTB20-AS1	-0.57301	0.034421	0.034421	-2.22222	Down	ZBTB20 antisense RNA 1	
TRIM63	-0.57147	0.026027	0.026027	-2.3489	Down	tripartite motif containing 63	
KCNG2	-0.57145	0.033467	0.033467	-2.23511	Down	potassium voltage-gated channel modifier subfamily G member 2	
LOC101929130	-0.57061	0.024183	0.024183	-2.38166	Down	uncharacterized LOC101929130	
CCDC136	-0.56956	0.01757	0.01757	-2.52176	Down	coiled-coil domain containing 136	
LYPLAL1-DT	-0.56901	0.033136	0.033136	-2.23967	Down	LYPLAL1 divergent transcript	
SULT1A1	-0.56533	0.015341	0.015341	-2.58019	Down	sulfotransferase family 1A member 1	
LINC02728	-0.56482	0.041126	0.041126	-2.13972	Down	long intergenic non-protein coding RNA 2728	
HIGD1C	-0.56081	0.033813	0.033813	-2.2304	Down	HIG1 hypoxia inducible domain family member 1C	
MYO7B	-0.56059	0.041943	0.041943	-2.13051	Down	myosin VIIB	
OR3A1	-0.55924	0.026476	0.026476	-2.34125	Down	olfactory receptor family 3 subfamily A member 1 (gene/pseudogene)	
CD2	-0.55858	0.027018	0.027018	-2.33215	Down	CD2 molecule	
CD248	-0.55695	0.037471	0.037471	-2.18305	Down	CD248 molecule	
C3orf80	-0.55604	0.020563	0.020563	-2.45323	Down	chromosome 3 open reading frame 80	
SIGLEC16	-0.55588	0.029906	0.029906	-2.28635	Down	sialic acid binding Ig like lectin 16 (gene/pseudogene)	
ICAM5	-0.55287	0.038001	0.038001	-2.17654	Down	intercellular adhesion molecule 5	
LINC02593	-0.55209	0.024742	0.024742	-2.37149	Down	long intergenic non-protein coding RNA 2593	
BLNK	-0.54887	0.015616	0.015616	-2.57256	Down	B cell linker	
SMOC2	-0.54705	0.035838	0.035838	-2.20365	Down	SPARC related modular calcium binding 2	
SLC16A12	-0.54659	0.03348	0.03348	-2.23494	Down	solute carrier family 16 member 12	
CD200R1	-0.53901	0.010696	0.010696	-2.73282	Down	CD200 receptor 1	
RFX8	-0.53709	0.037009	0.037009	-2.1888	Down	RFX family member 8, lacking RFX DNA binding domain	
SLC15A2	-0.5366	0.037165	0.037165	-2.18685	Down	solute carrier family 15 member 2	
COLCA1	-0.53394	0.026332	0.026332	-2.34368	Down	colorectal cancer associated 1	
FNDC5	-0.53191	0.04585	0.04585	-2.08855	Down	fibronectin type III domain containing 5	
TRIM50	-0.53099	0.023565	0.023565	-2.39315	Down	tripartite motif containing 50	
HPD	-0.52962	0.030271	0.030271	-2.28086	Down	4-hydroxyphenylpyruvate dioxygenase	
DIRAS3	-0.52645	0.042268	0.042268	-2.1269	Down	DIRAS family GTPase 3	
TRPV4	-0.52594	0.01629	0.01629	-2.5544	Down	transient receptor potential cation channel subfamily V member 4	
PDGFD	-0.52569	0.036484	0.036484	-2.1954	Down	platelet derived growth factor D	
LRRC2	-0.52497	0.004795	0.004795	-3.06064	Down	leucine rich repeat containing 2	
BAMBI	-0.52363	0.00058	0.00058	-3.87367	Down	BMP and activin membrane bound inhibitor	
MRC1	-0.52267	0.008283	0.008283	-2.8389	Down	mannose receptor C-type 1	
LIPM	-0.52188	0.032968	0.032968	-2.24199	Down	lipase family member M	
FCGR2B	-0.52033	0.028388	0.028388	-2.3099	Down	Fc fragment of IgG receptor IIb	
NEXN	-0.51863	2.22E-05	2.22E-05	-5.07043	Down	nexilin F-actin binding protein	
CGREF1	-0.51368	0.021369	0.021369	-2.43635	Down	cell growth regulator with EF-hand domain 1	
TLR7	-0.51345	0.01367	0.01367	-2.62939	Down	toll like receptor 7	
RUNX2	-0.51175	0.015836	0.015836	-2.56656	Down	RUNX family transcription factor 2	
NANOS1	-0.51061	0.010494	0.010494	-2.7408	Down	nanos C2HC-type zinc finger 1	
CD163L1	-0.51047	0.023747	0.023747	-2.38974	Down	CD163 molecule like 1	
RNASE1	-0.50647	0.007879	0.007879	-2.85947	Down	ribonuclease A family member 1, pancreatic	
SIGLEC11	-0.50389	0.014684	0.014684	-2.59893	Down	sialic acid binding Ig like lectin 11	
KLRD1	-0.5033	0.031927	0.031927	-2.25665	Down	killer cell lectin like receptor D1	
COL12A1	-0.50322	0.004436	0.004436	-3.09172	Down	collagen type XII alpha 1 chain	
GLIPR2	-0.50158	0.017678	0.017678	-2.51911	Down	GLI pathogenesis related 2	
LOX	-0.49993	0.009205	0.009205	-2.7953	Down	lysyl oxidase	
LOC339192	-0.4991	0.004991	0.004991	-3.04463	Down	uncharacterized LOC339192	
LOC100507477	-0.49658	0.012644	0.012644	-2.66249	Down	uncharacterized LOC100507477	
SLC5A1	-0.49615	0.029007	0.029007	-2.30017	Down	solute carrier family 5 member 1	
ADARB2	-0.49613	0.047885	0.047885	-2.06793	Down	adenosine deaminase RNA specific B2 (inactive)	
HTR1F	-0.49612	0.029137	0.029137	-2.29815	Down	5-hydroxytryptamine receptor 1F	
ADRA1B	-0.49337	0.040435	0.040435	-2.14765	Down	adrenoceptor alpha 1B	
ADAM12	-0.49149	0.003101	0.003101	-3.23333	Down	ADAM metallopeptidase domain 12	
ASAH1	-0.49116	0.010546	0.010546	-2.73872	Down	N-acylsphingosineamidohydrolase 1	
F2R	-0.48858	0.00113	0.00113	-3.6225	Down	coagulation factor II thrombin receptor	
SCN9A	-0.48853	0.011298	0.011298	-2.70989	Down	sodium voltage-gated channel alpha subunit 9	
VNN1	-0.48719	0.045559	0.045559	-2.09156	Down	vanin 1	
CLCA2	-0.48349	0.025225	0.025225	-2.36288	Down	chloride channel accessory 2	
PALLD	-0.48322	0.021141	0.021141	-2.44107	Down	palladin, cytoskeletal associated protein	
FAM234B	-0.48245	0.00126	0.00126	-3.58132	Down	family with sequence similarity 234 member B	
TKTL2	-0.47941	0.007788	0.007788	-2.86422	Down	transketolase like 2	
IL1RAPL2	-0.47891	0.027206	0.027206	-2.32904	Down	interleukin 1 receptor accessory protein like 2	
ALDH1A3	-0.47731	0.03362	0.03362	-2.23302	Down	aldehyde dehydrogenase 1 family member A3	
METTL21C	-0.47463	0.049049	0.049049	-2.05649	Down	methyltransferase like 21C	
LOXL1	-0.47425	0.001529	0.001529	-3.50725	Down	lysyl oxidase like 1	
XKRX	-0.47305	0.047636	0.047636	-2.07042	Down	XK related X-linked	
WDR66	-0.47255	0.025331	0.025331	-2.36101	Down	WD repeat domain 66	
CRABP2	-0.47169	0.036907	0.036907	-2.19008	Down	cellular retinoic acid binding protein 2	
C1QA	-0.46939	0.036047	0.036047	-2.20097	Down	complement C1q A chain	
ETV5	-0.46625	0.002936	0.002936	-3.2548	Down	ETS variant transcription factor 5	
GPR62	-0.46587	0.03508	0.03508	-2.2135	Down	G protein-coupled receptor 62	
LINC00565	-0.46566	0.016548	0.016548	-2.54762	Down	long intergenic non-protein coding RNA 565	
CCDC167	-0.46454	0.018942	0.018942	-2.4891	Down	coiled-coil domain containing 167	
OTUD7A	-0.46045	0.025299	0.025299	-2.36158	Down	OTU deubiquitinase 7A	
RND3	-0.45828	0.001137	0.001137	-3.62035	Down	Rho family GTPase 3	
FN1	-0.45811	0.040207	0.040207	-2.15029	Down	fibronectin 1	
PCDHA6	-0.45753	0.023652	0.023652	-2.39151	Down	protocadherin alpha 6	
DBX2	-0.45586	0.017039	0.017039	-2.53503	Down	developing brain homeobox 2	
MAMDC2	-0.45565	0.042331	0.042331	-2.12619	Down	MAM domain containing 2	
WDR93	-0.45371	0.02124	0.02124	-2.439	Down	WD repeat domain 93	
UCHL1	-0.45268	0.026356	0.026356	-2.34327	Down	ubiquitin C-terminal hydrolase L1	
SERPINE2	-0.45078	0.028886	0.028886	-2.30205	Down	serpin family E member 2	
AADACL2	-0.44945	0.01659	0.01659	-2.54653	Down	arylacetamidedeacetylase like 2	
SERPINB7	-0.4478	0.047833	0.047833	-2.06845	Down	serpin family B member 7	
FAM225A	-0.44693	0.011918	0.011918	-2.68743	Down	family with sequence similarity 225 member A	
C10orf90	-0.44605	0.015297	0.015297	-2.58142	Down	chromosome 10 open reading frame 90	
FBLL1	-0.44578	0.01963	0.01963	-2.47353	Down	fibrillarin like 1	
NBPF6	-0.44335	0.021245	0.021245	-2.4389	Down	NBPF member 6	
FTMT	-0.44299	0.049479	0.049479	-2.05232	Down	ferritin mitochondrial	
LINC01920	-0.44193	0.043385	0.043385	-2.11463	Down	long intergenic non-protein coding RNA 1920	
BEND4	-0.44007	0.046768	0.046768	-2.07915	Down	BEN domain containing 4	
LINC02338	-0.4399	0.043605	0.043605	-2.11226	Down	long intergenic non-protein coding RNA 2338	
HHLA2	-0.43741	0.01909	0.01909	-2.48571	Down	HERV-H LTR-associating 2	
HGF	-0.43398	0.013508	0.013508	-2.63446	Down	hepatocyte growth factor	
HEXIM1	-0.43356	0.004293	0.004293	-3.10478	Down	HEXIM P-TEFb complex subunit 1	
DGKI	-0.43244	0.01747	0.01747	-2.52421	Down	diacylglycerol kinase iota	
FILIP1L	-0.43169	0.002395	0.002395	-3.33416	Down	filamin A interacting protein 1 like	
EFCAB7	-0.43071	0.023889	0.023889	-2.3871	Down	EF-hand calcium binding domain 7	
SLC4A7	-0.43025	0.010957	0.010957	-2.72274	Down	solute carrier family 4 member 7	
ZFAT	-0.42877	0.002173	0.002173	-3.37191	Down	zinc finger and AT-hook domain containing	
C10orf143	-0.42858	0.008135	0.008135	-2.84633	Down	chromosome 10 open reading frame 143	
TNFRSF19	-0.42847	0.037177	0.037177	-2.18671	Down	TNF receptor superfamily member 19	
FAM83A	-0.42751	0.039597	0.039597	-2.15742	Down	family with sequence similarity 83 member A	
GABRB1	-0.42732	0.035765	0.035765	-2.2046	Down	gamma-aminobutyric acid type A receptor beta1 subunit	
NOX4	-0.42605	0.02526	0.02526	-2.36227	Down	NADPH oxidase 4	
CCND2	-0.42423	0.021978	0.021978	-2.42397	Down	cyclin D2	
THAP10	-0.42349	0.022044	0.022044	-2.42265	Down	THAP domain containing 10	
TPTEP1	-0.42268	0.020941	0.020941	-2.44524	Down	TPTE pseudogene 1	
HLA-DRB1	-0.42192	0.021662	0.021662	-2.43035	Down	major histocompatibility complex, class II, DR beta 1	
LILRB5	-0.42095	0.035206	0.035206	-2.21185	Down	leukocyte immunoglobulin like receptor B5	
STAB1	-0.42046	0.028034	0.028034	-2.31555	Down	stabilin 1	
NAIP	-0.41965	0.028516	0.028516	-2.30788	Down	NLR family apoptosis inhibitory protein	
GALNT16	-0.41849	0.032852	0.032852	-2.2436	Down	polypeptide N-acetylgalactosaminyltransferase 16	
WWC1	-0.41823	0.042955	0.042955	-2.11932	Down	WW and C2 domain containing 1	
COL3A1	-0.4161	0.012907	0.012907	-2.65376	Down	collagen type III alpha 1 chain	
MIR6809	-0.41533	0.042532	0.042532	-2.12397	Down	microRNA 6809	
JAZF1	-0.41531	0.007662	0.007662	-2.87091	Down	JAZF zinc finger 1	
GALNT7	-0.41474	0.00206	0.00206	-3.39265	Down	polypeptide N-acetylgalactosaminyltransferase 7	
SLC30A1	-0.41231	0.044132	0.044132	-2.10659	Down	solute carrier family 30 member 1	
SLC24A3	-0.41214	0.004843	0.004843	-3.05668	Down	solute carrier family 24 member 3	
IL20RB	-0.41053	0.034294	0.034294	-2.22392	Down	interleukin 20 receptor subunit beta	
TMEM200A	-0.41005	0.021657	0.021657	-2.43046	Down	transmembrane protein 200A	
LOC100505549	-0.40982	0.023119	0.023119	-2.40162	Down	uncharacterized LOC100505549	
HACD4	-0.40883	0.022474	0.022474	-2.41412	Down	3-hydroxyacyl-CoA dehydratase 4	
FMOD	-0.40733	0.018574	0.018574	-2.49765	Down	fibromodulin	
MARCKS	-0.40702	0.030225	0.030225	-2.28156	Down	myristoylated alanine rich protein kinase C substrate	
GLB1	-0.40571	0.002763	0.002763	-3.27859	Down	galactosidase beta 1	
CSF1R	-0.40406	0.046599	0.046599	-2.08087	Down	colony stimulating factor 1 receptor	
ADGRG6	-0.40323	0.045778	0.045778	-2.0893	Down	adhesion G protein-coupled receptor G6	
PIK3R2	-0.40255	0.018858	0.018858	-2.49105	Down	phosphoinositide-3-kinase regulatory subunit 2	
PTGFRN	-0.40253	0.007558	0.007558	-2.8765	Down	prostaglandin F2 receptor inhibitor	
TACR1	-0.4014	0.022803	0.022803	-2.40771	Down	tachykinin receptor 1	
INSM1	-0.40121	0.043164	0.043164	-2.11704	Down	INSM transcriptional repressor 1	
CYBB	-0.40065	0.04148	0.04148	-2.13572	Down	cytochrome b-245 beta chain	
NRP2	-0.39927	0.007496	0.007496	-2.87988	Down	neuropilin 2	
ARRDC4	-0.39869	0.004531	0.004531	-3.08331	Down	arrestin domain containing 4	
ASPN	-0.39605	0.018067	0.018067	-2.50967	Down	asporin	
CTSW	-0.39553	0.037568	0.037568	-2.18186	Down	cathepsin W	
CACNA1C	-0.39553	0.030995	0.030995	-2.27013	Down	calcium voltage-gated channel subunit alpha1 C	
SNHG21	-0.39342	0.015072	0.015072	-2.58776	Down	small nucleolar RNA host gene 21	
ITGAV	-0.39277	0.001011	0.001011	-3.6648	Down	integrin subunit alpha V	
LUM	-0.39237	0.048966	0.048966	-2.0573	Down	lumican	
TPM2	-0.39197	0.024526	0.024526	-2.3754	Down	tropomyosin 2	
DAB2	-0.39195	4.44E-05	4.44E-05	-4.81792	Down	DAB adaptor protein 2	
GGTA1P	-0.38792	0.018167	0.018167	-2.50726	Down	glycoprotein alpha-galactosyltransferase 1, pseudogene	
MIMT1	-0.38785	0.036712	0.036712	-2.19253	Down	MER1 repeat containing imprinted transcript 1	
OR9Q2	-0.38734	0.03162	0.03162	-2.26104	Down	olfactory receptor family 9 subfamily Q member 2	
FAM20A	-0.38702	0.036624	0.036624	-2.19364	Down	FAM20A golgi associated secretory pathway pseudokinase	
PMEPA1	-0.38651	0.009631	0.009631	-2.77655	Down	prostate transmembrane protein, androgen induced 1	
SAMSN1	-0.38607	0.027046	0.027046	-2.33168	Down	SAM domain, SH3 domain and nuclear localization signals 1	
TAFA2	-0.38579	0.046957	0.046957	-2.07723	Down	TAFA chemokine like family member 2	
SLC6A7	-0.38559	0.04736	0.04736	-2.07317	Down	solute carrier family 6 member 7	
CKMT2-AS1	-0.38548	0.045796	0.045796	-2.08911	Down	CKMT2 antisense RNA 1	
MPEG1	-0.38475	0.032517	0.032517	-2.24829	Down	macrophage expressed 1	
C19orf18	-0.38407	0.04723	0.04723	-2.07448	Down	chromosome 19 open reading frame 18	
KLHL29	-0.38309	0.035953	0.035953	-2.20218	Down	kelch like family member 29	
CERCAM	-0.38247	0.019646	0.019646	-2.47319	Down	cerebral endothelial cell adhesion molecule	
ETV1	-0.38153	0.029051	0.029051	-2.29948	Down	ETS variant transcription factor 1	
BDKRB2	-0.38151	0.040133	0.040133	-2.15114	Down	bradykinin receptor B2	
GRHL1	-0.37827	0.012852	0.012852	-2.65557	Down	grainyhead like transcription factor 1	
OTULINL	-0.37674	0.028403	0.028403	-2.30967	Down	OTU deubiquitinase with linear linkage specificity like	
RGL1	-0.37613	0.000119	0.000119	-4.45727	Down	ral guanine nucleotide dissociation stimulator like 1	
RPL13P5	-0.37585	0.048146	0.048146	-2.06535	Down	ribosomal protein L13 pseudogene 5	
ZNF488	-0.37547	0.047689	0.047689	-2.06988	Down	zinc finger protein 488	
SLC25A14	-0.37434	0.008636	0.008636	-2.82168	Down	solute carrier family 25 member 14	
LINC01140	-0.37257	0.004509	0.004509	-3.08519	Down	long intergenic non-protein coding RNA 1140	
UGDH	-0.37133	0.02146	0.02146	-2.43449	Down	UDP-glucose 6-dehydrogenase	
ENC1	-0.37101	0.018286	0.018286	-2.50442	Down	ectodermal-neural cortex 1	
RTL9	-0.36928	0.047629	0.047629	-2.07048	Down	retrotransposon Gag like 9	
IQGAP2	-0.36865	0.037295	0.037295	-2.18524	Down	IQ motif containing GTPase activating protein 2	
ALDH1L2	-0.36654	0.000623	0.000623	-3.84689	Down	aldehyde dehydrogenase 1 family member L2	
GPR34	-0.36515	0.039956	0.039956	-2.15321	Down	G protein-coupled receptor 34	
GRAMD1B	-0.36456	0.044696	0.044696	-2.1006	Down	GRAM domain containing 1B	
MAN1A1	-0.36373	0.006066	0.006066	-2.96604	Down	mannosidase alpha class 1A member 1	
RABIF	-0.36301	0.002326	0.002326	-3.34563	Down	RAB interacting factor	
TEC	-0.36224	0.005923	0.005923	-2.97566	Down	tec protein tyrosine kinase	
FICD	-0.36185	0.000247	0.000247	-4.19042	Down	FIC domain containing	
PLXDC1	-0.36111	0.037452	0.037452	-2.18329	Down	plexin domain containing 1	
C1orf146	-0.36015	0.038798	0.038798	-2.1669	Down	chromosome 1 open reading frame 146	
DYNC1I1	-0.35903	0.043271	0.043271	-2.11587	Down	dynein cytoplasmic 1 intermediate chain 1	
MFAP4	-0.35865	0.014841	0.014841	-2.59438	Down	microfibril associated protein 4	
FRMD4B	-0.35817	0.040289	0.040289	-2.14934	Down	FERM domain containing 4B	
P2RY13	-0.35797	0.029676	0.029676	-2.28985	Down	purinergic receptor P2Y13	
HRH1	-0.35784	0.044282	0.044282	-2.10499	Down	histamine receptor H1	
FBN1	-0.35729	0.008031	0.008031	-2.85159	Down	fibrillin 1	
COL5A2	-0.35639	0.000402	0.000402	-4.01019	Down	collagen type V alpha 2 chain	
ALX4	-0.35556	0.024298	0.024298	-2.37955	Down	ALX homeobox 4	
CCDC80	-0.35542	0.001101	0.001101	-3.63236	Down	coiled-coil domain containing 80	
SNCAIP	-0.35503	0.013865	0.013865	-2.62339	Down	synuclein alpha interacting protein	
IKBIP	-0.354	0.02324	0.02324	-2.3993	Down	IKBKB interacting protein	
BICC1	-0.35252	0.004878	0.004878	-3.05381	Down	BicC family RNA binding protein 1	
CAMK2N1	-0.34899	0.047228	0.047228	-2.0745	Down	calcium/calmodulin dependent protein kinase II inhibitor 1	
TMEM67	-0.34689	0.024989	0.024989	-2.36708	Down	transmembrane protein 67	
LIMCH1	-0.34449	0.005071	0.005071	-3.0382	Down	LIM and calponin homology domains 1	
GNG2	-0.34436	0.017366	0.017366	-2.52679	Down	G protein subunit gamma 2	
TRAM2	-0.34185	0.001914	0.001914	-3.42104	Down	translocation associated membrane protein 2	
VLDLR	-0.34162	0.011677	0.011677	-2.69604	Down	very low density lipoprotein receptor	
TTYH2	-0.33982	0.049674	0.049674	-2.05044	Down	tweety family member 2	
P4HA2	-0.33879	0.00227	0.00227	-3.35509	Down	prolyl 4-hydroxylase subunit alpha 2	
FER1L6	-0.33814	0.027267	0.027267	-2.32803	Down	fer-1 like family member 6	
GEM	-0.33728	0.005769	0.005769	-2.98636	Down	GTP binding protein overexpressed in skeletal muscle	
RCN3	-0.33692	0.02923	0.02923	-2.2967	Down	reticulocalbin 3	
IMPAD1	-0.33553	0.005228	0.005228	-3.02597	Down	inositol monophosphatase domain containing 1	
SESN1	-0.33492	0.006934	0.006934	-2.91171	Down	sestrin 1	
GPR137B	-0.33349	0.036019	0.036019	-2.20133	Down	G protein-coupled receptor 137B	
SPARC	-0.33102	0.007711	0.007711	-2.86828	Down	secreted protein acidic and cysteine rich	
ZDHHC20	-0.33048	0.021857	0.021857	-2.4264	Down	zinc finger DHHC-type containing 20	
CPXM2	-0.32867	0.027253	0.027253	-2.32826	Down	carboxypeptidase X, M14 family member 2	
RRN3P2	-0.32859	0.018624	0.018624	-2.49648	Down	RRN3 homolog, RNA polymerase I transcription factor pseudogene 2	
SEMA3C	-0.32851	0.017989	0.017989	-2.51154	Down	semaphorin 3C	
DACT1	-0.32813	0.03652	0.03652	-2.19495	Down	dishevelled binding antagonist of beta catenin 1	
SPDYE17	-0.32802	0.04574	0.04574	-2.08968	Down	speedy/RINGO cell cycle regulator family member E17	
LINC01963	-0.32754	0.012373	0.012373	-2.67163	Down	long intergenic non-protein coding RNA 1963	
GIN1	-0.32533	0.038359	0.038359	-2.17219	Down	gypsy retrotransposonintegrase 1	
HECTD2	-0.32446	0.036485	0.036485	-2.19539	Down	HECT domain E3 ubiquitin protein ligase 2	
PTGER4	-0.32374	0.014657	0.014657	-2.5997	Down	prostaglandin E receptor 4	
PRNP	-0.32047	0.00413	0.00413	-3.12014	Down	prion protein	
MAP 1B	-0.32035	0.015796	0.015796	-2.56765	Down	microtubule associated protein 1B	
GAS1RR	-0.31983	0.042327	0.042327	-2.12624	Down	GAS1 adjacent regulatory RNA	
ZNF107	-0.31823	0.00885	0.00885	-2.81159	Down	zinc finger protein 107	
FSTL3	-0.31787	0.020675	0.020675	-2.45085	Down	follistatin like 3	
PKD1L3	-0.31687	0.0431	0.0431	-2.11773	Down	polycystin 1 like 3, transient receptor potential channel interacting	
PAG1	-0.31685	0.019249	0.019249	-2.48211	Down	phosphoprotein membrane anchor with glycosphingolipidmicrodomains 1	
TMPPE	-0.31551	0.000808	0.000808	-3.74957	Down	transmembrane protein with metallophosphoesterase domain	
FRRS1L	-0.31367	0.047263	0.047263	-2.07416	Down	ferric chelate reductase 1 like	
WDR78	-0.31163	0.036163	0.036163	-2.19948	Down	WD repeat domain 78	
OLFML2B	-0.31035	0.034022	0.034022	-2.22757	Down	olfactomedin like 2B	
SH3RF3	-0.31019	0.019582	0.019582	-2.4746	Down	SH3 domain containing ring finger 3	
SLC38A6	-0.30913	0.045079	0.045079	-2.09657	Down	solute carrier family 38 member 6	
GBP4	-0.30841	0.017695	0.017695	-2.51868	Down	guanylate binding protein 4	
ZNF678	-0.30546	0.016314	0.016314	-2.55377	Down	zinc finger protein 678	
CYTOR	-0.30436	0.014748	0.014748	-2.59705	Down	cytoskeleton regulator RNA	
TDRD15	-0.30397	0.022379	0.022379	-2.416	Down	tudor domain containing 15	
ARHGAP18	-0.30123	0.003517	0.003517	-3.18376	Down	Rho GTPase activating protein 18	
INSYN2A	-0.29921	0.007796	0.007796	-2.86381	Down	inhibitory synaptic factor 2A	
SLC2A10	-0.29836	0.011493	0.011493	-2.7027	Down	solute carrier family 2 member 10	
TENM1	-0.29763	0.023018	0.023018	-2.40355	Down	teneurintransmembrane protein 1	
COLEC12	-0.29666	0.027788	0.027788	-2.31953	Down	collectin subfamily member 12	
MTSS1	-0.29656	0.021939	0.021939	-2.42476	Down	MTSS I-BAR domain containing 1	
FSTL1	-0.29568	0.004621	0.004621	-3.07542	Down	follistatin like 1	
KLF10	-0.29395	0.015541	0.015541	-2.57463	Down	Kruppel like factor 10	
UGP2	-0.29329	0.044865	0.044865	-2.09882	Down	UDP-glucose pyrophosphorylase 2	
SLC9A9	-0.29287	0.005573	0.005573	-3.00025	Down	solute carrier family 9 member A9	
LPAR1	-0.29287	0.008363	0.008363	-2.83493	Down	lysophosphatidic acid receptor 1	
GABRG1	-0.29068	0.037398	0.037398	-2.18397	Down	gamma-aminobutyric acid type A receptor gamma1 subunit	
PDLIM1	-0.29033	0.018561	0.018561	-2.49795	Down	PDZ and LIM domain 1	
EEA1	-0.29004	0.01712	0.01712	-2.53298	Down	early endosome antigen 1	
RUNX1	-0.28986	0.039414	0.039414	-2.15957	Down	RUNX family transcription factor 1	
MTHFD1L	-0.28913	0.046147	0.046147	-2.08549	Down	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like	
MIR4435-2HG	-0.28849	0.007052	0.007052	-2.90483	Down	MIR4435-2 host gene	
FAM118B	-0.28811	0.005667	0.005667	-2.99355	Down	family with sequence similarity 118 member B	
CASP6	-0.28807	0.038673	0.038673	-2.16841	Down	caspase 6	
MAN2A1	-0.28713	0.008895	0.008895	-2.80947	Down	mannosidase alpha class 2A member 1	
LINC02693	-0.28672	0.036645	0.036645	-2.19337	Down	long intergenic non-protein coding RNA 2693	
C2CD6	-0.28663	0.049977	0.049977	-2.04753	Down	C2 calcium dependent domain containing 6	
SOCS5	-0.28573	0.039472	0.039472	-2.15889	Down	suppressor of cytokine signaling 5	
MTF1	-0.28509	0.039683	0.039683	-2.15641	Down	metal regulatory transcription factor 1	
ATRN	-0.28445	2.25E-05	2.25E-05	-5.06531	Down	attractin	
ENTHD1	-0.28253	0.03304	0.03304	-2.24099	Down	ENTH domain containing 1	
ZNF569	-0.28241	0.032207	0.032207	-2.25265	Down	zinc finger protein 569	
SYNC	-0.28167	0.026701	0.026701	-2.33744	Down	syncoilin, intermediate filament protein	

Gene ontology and pathway enrichment analyses

DEGs were divided into up regulated genes and down regulated genes. GO and REACTOME pathway enrichment analysis were conducted for DEGs. Results of GO categories were presented by functional groups, which include BP, CC, and MF, and are listed in Table 3. In group BP, up regulated genes enriched in regulation of ion transmembrane transport and oxoacid metabolic process, while the down regulated genes enriched in cell adhesion and response to endogenous stimulus. For group CC, up regulated genes enriched in intrinsic component of plasma membrane and mitochondrion, while down regulated genes enriched in integral component of plasma membrane and supra molecular fiber. In addition, GO results of group MF showed that up regulated genes enriched in transferase activity, transferring phosphorus-containing groups and transporter activity and down regulated genes enriched in signaling receptor binding and molecular transducer activity. Several significant enriched pathways were acquired through REACTOME pathway analysis (Table 4). The enriched pathways for up regulated genes included integration of energy metabolism and neuronal system, while, down regulated genes enriched in extracellular matrix organization and GPCR ligand binding. Table 3 The enriched GO terms of the up and down regulated differentially expressed genes

GO ID	CATEGORY	GO Name	P Value	FDR B&H	FDR B&Y	Bonferroni	Gene Count	Gene	
Up regulated genes	
 GO:0034765	BP	regulation of ion transmembrane transport	2.49E-04	9.88E-02	8.85E-01	1.00E+00	21	KCNE5,RRAD,SLC9A3R2,SLC9A3R1,NRXN1,RAPGEF3,SCN4A,SHANK3,CRHR1,SHANK2,SPHK2,PSEN2,PTPN3,VAMP2,CACNA1A,KCNE2,CACNB2,TMC2,CASQ2,KCNK7,EDNRA	
 GO:0043436	BP	oxoacid metabolic process	9.54E-04	1.64E-01	1.00E+00	1.00E+00	35	ACADS,ACAT2,GGT6,PFKFB3,PGAM2,ADH1B,CKB,FASN,PLIN5,MPST,SLC6A8,CSPG4,EGFLAM,PRODH,CYP2E1,SREBF1,GCK,ALDH1L1,TYSND1,ACSS2,ITIH1,LDHD,ADHFE1,GK,SULT1C2,SPHK1,GLUL,GPT2,CACNA1A,ANKRD23,MLXIPL,GCAT,AASS,HADH,DCXR	
 GO:0031226	CC	intrinsic component of plasma membrane	3.56E-04	2.11E-02	1.44E-01	1.90E-01	48	EPHB4,HLA-DQA1,KCNE5,CD320,REEP2,NRXN1,SCN4A,NPC1L1,RAB26,ALK,CNTFR,ADCY4,ACVR1C,SHANK3,CRHR1,SLC2A4,SLC6A8,SHANK2,GPIHBP1,PLPP2,SLC26A7,CSPG4,EBP,FUT1,SLC4A4,SLC16A13,PSEN2,ADGRB3,FGFRL1,SLC30A3,SEMA4C,VAMP2,CA4,CACNA1A,KCNE2,DDR1,CACNB2,STBD1,TMC2,PCDHGC4,SLC19A3,SLC35G2,DLL1,EDA,KCNK7,SYT7,EDNRA,TGM2	
 GO:0005739	CC	mitochondrion	2.66E-03	6.74E-02	4.62E-01	1.00E+00	46	HDHD3,ACADS,ACAT2,ESR2,GLYCTK,RDH13,YJEFN3,CKB,PCBD2,FASN,PLIN5,MPST,ADCK5,LGALS12,SLC25A10,MRPL11,PRODH,SPHK2,CYP2E1,MYOC,GCK,ALDH1L1,STOX1,ACSS2,POLR1G,LDHD,ADHFE1,GK,BOK,COQ8A,GLUL,PXMP2,MAIP1,GPT2,MGARP,TDRKH,DEPP1,ECHDC3,SLC25A22,TGM2,GCAT,AASS,SLC25A52,HADH,TMEM143,TP73	
 GO:0016772	MF	transferase activity, transferring phosphorus-containing groups	1.80E-04	4.04E-02	2.98E-01	1.62E-01	52	CDK20,EPHB4,GPHN,CDKN2C,DAPK2,GLYCTK,CARD10,PFKFB3,PGAM2,MAP 3K5,CKB,CISH,SLC9A3R1,NRXN1,PI4KAP1,ALPK3,TAB1,ALK,MOCS1,PKN3,ANKK1,ADCY4,ADCK5,WNT11,ACVR1C,AATK,NEK8,CSPG4,PNCK,SPHK2,PSEN2,IRAK2,FGFRL1,GCK,STOX1,POLR1G,RASIP1,GK,COQ8A,SPHK1,CCNA1,GNG3,CCNJL,DDR1,POLM,MKNK2,WASHC1,SRCIN1,RGS3,EDNRA,MLXIPL,TP73	
 GO:0005215	MF	transporter activity	2.72E-03	1.37E-01	1.00E+00	1.00E+00	40	KCNE5,RRAD,CD320,SLC9A3R1,NRXN1,RAPGEF3,SCN4A,NPC1L1,SVOP,APOB,SHROOM2,SHANK3,CRHR1,SLC2A4,SLC6A8,SHANK2,GPIHBP1,SLC26A7,EBP,SLC25A10,SLC4A4,SLC2A11,SPHK2,SLC16A13,AZGP1,CPLX1,SLC30A3,APOM,PTPN3,VAMP2,CACNA1A,KCNE2,CACNB2,TMC2,INAFM1,SLC19A3,TMEM63C,CASQ2,KCNK7,SLC25A22	
Down regulated genes	
 GO:0046649	BP	lymphocyte activation	1.37E-15	5.40E-12	4.78E-11	5.40E-12	40	HLA-DMB,HLA-DPA1,SPTA1,BCL11A,ITGA4,FGL2,CXCR5,FCRL1,PTPRC,ZC3H12D,FBXO7,CCR7,NOTCH2,TCF7,IKZF3,POLM,CAMK4,POU2F2,BTLA,CR1,CBLB,SLC4A1,TFRC,BCL11B,CD4,CD5,CD6,MS4A1,CD22,CD27,CD44,TNFRSF13C,TNFRSF13B,CD79A,RORA,ATM,LY9,LEF1,IL7R,NCKAP1L	
 GO:0010941	BP	regulation of cell death	9.53E-05	6.03E-03	5.34E-02	3.75E-01	40	STK17B,OBSCN,ITGA4,NR4A1,STRADB,BNIP3L,PTPRC,BTG1,TMC8,FBXO7,PLAGL2,CCR7,NOTCH2,TCF7,IKZF3,OGT,CAMK1D,BMF,NLRP1,GRINA,OPA1,EEF1A1,TXNIP,BCL11B,IGF2R,CSF1R,CD27,NEURL1,CD44,LRP1,ATM,HBA1,HBA2,HBB,CTSB,LEF1,RPL10,IL7R,SORL1,NCKAP1L	
 GO:0009986	CC	cell surface	2.02E-09	3.10E-07	2.08E-06	9.30E-07	35	ADAM19,HLA-DPA1,HLA-DRA,ITGA4,CXCR5,FCRL1,PTPRC,CIITA,MRC2,CCR7,NOTCH2,SEMA7A,BTLA,CR1,SLC4A1,TFRC,CD4,CD5,IGF2R,CD6,CSF1R,MS4A1,CLEC17A,CD22,CD27,GYPA,VCAN,CD44,CLEC2D,TNFRSF13C,TNFRSF13B,CD79A,LY9,CTSB,IL7R	
 GO:0031226	CC	intrinsic component of plasma membrane	5.35E-07	4.11E-05	2.76E-04	2.47E-04	43	HLA-DPA1,HLA-DRA,SPTA1,SLC38A5,ITGA4,SLC38A1,CXCR5,PTPRC,SLC24A4,TMC8,NOTCH2,VIPR1,TRABD2A,SEMA7A,BTLA,SLC7A6,CR1,MCOLN1,SLC2A1,TSPAN5,RHAG,SLC4A1,TFRC,CELSR1,CD4,CD5,IGF2R,CD6,CSF1R,P2RX5,MS4A1,SLC14A1,CD22,CD27,GYPA,GYPB,CD44,CLEC2D,LRP1,TNFRSF13B,ATP2B1,SORL1,NCKAP1L	
 GO:0016772	MF	transferase activity, transferring phosphorus-containing groups	9.72E-04	4.32E-02	3.09E-01	6.92E-01	35	ZBTB20,RPS6KA5,STK17B,OBSCN,TENT5C,TTN,PIK3IP1,BLK,STRADB,PTPRC,CIITA,FBXO7,CCR7,DYRK2,OGT,CAMK1D,CTC1,POLM,CAMK4,DUSP2,AAK1,CBLB,SLC4A1,EEF1A1,RMRP,CD4,IGF2R,CSF1R,NEURL1,CD44,LRP1,ATM,SERINC5,SORL1,NCKAP1L	
 GO:0008144	MF	drug binding	1.15E-02	1.55E-01	1.00E+00	1.00E+00	30	ABCA2,RPS6KA5,STK17B,OBSCN,TTN,BLK,STRADB,CIITA,ALAS2,ABCD2,DYRK2,DNHD1,ACSL6,CAMK1D,EP400,ATP13A1,CAMK4,AAK1,NLRP1,EEF1A1,DNAH1,CSF1R,P2RX5,ATM,HBA1,HBA2,HBM,HBB,ATP2B1,EPB42	
Biological Process (BP), Cellular Component (CC) and Molecular Functions (MF)

Table 4 The enriched pathway terms of the up and down regulated differentially expressed genes

Pathway ID	Pathway Name	P-value	FDR B&H	FDR B&Y	Bonferroni	Gene Count	Gene	
Up regulated genes	
 1269340	Hemostasis	4.28E-06	7.47E-04	5.11E-03	2.24E-03	22	GNG8,TRPC6,CEACAM6,CABLES1,SERPINE2,FGA,KCNMB1,FGB,HRG,PLA2G4A,MMP1,FGG,VEGFC,GRB14,APOB,APOH,ZFPM2,TGFB3,ORM1,TIMP1,CD63,PRKAR1B	
 1269741	Cell Cycle	8.91E-04	2.12E-02	1.45E-01	4.67E-01	17	CETN2,MND1,MCM10,GINS1,TYMS,H2BC17,H4C14,BUB1,H2BC11,UBE2C,H4C15,CENPU,E2F1,CCNB1,DMC1,CENPI,H2AJ	
 1269507	Signaling by Rho GTPases	1.14E-02	8.42E-02	5.76E-01	1.00E+00	11	PPP1R14A,TAX1BP3,H2BC17,H4C14,BUB1,WASF1,H2BC11,H4C15,CENPU,CENPI,H2AJ	
 1269203	Innate Immune System	7.89E-02	2.91E-01	1.00E+00	1.00E+00	21	CEACAM6,DEFA1,GLA,HP,VNN1,FGA,FGB,FGG,WASF1,PGLYRP1,APOB,RET,LCN2,POLR3G,DERA,ORM1,MS4A3,CYSTM1,CD63,PRKAR1B,MCEMP1	
 1270001	Metabolism of lipids and lipoproteins	1.52E-01	3.82E-01	1.00E+00	1.00E+00	13	ACER2,ACOT7,ME1,GLA,SPHK1,PLA2G4A,FHL2,PLAAT1,G0S2,THEM5,APOA2,APOB,SMPD1	
 1268677	Metabolism of proteins	3.37E-01	5.01E-01	1.00E+00	1.00E+00	21	GNG8,CETN2,FN3K,H2AC13,H2BC17,VNN1,SPHK1,H4C14,MITF,FGA,MMP1,RAB32,METTL22,DYNC1I1,H2BC11,ADAMTS1,UBE2C,H4C15,ADAMTS5,IGFBP2,AOPEP	
Down regulated genes	
 1269171	Adaptive Immune System	1.59E-03	8.64E-02	5.87E-01	7.96E-01	20	HLA-DMB,HLA-DPA1,HLA-DRA,TNRC6B,ITGA4,NR4A1,BLK,KLHL3,PTPRC,MRC2,FBXO7,RNF213,BTLA,CBLB,CD4,CD22,CLEC2D,CD79A,CTSB,RNF182	
 1269903	Transmembrane transport of small molecules	1.39E-02	1.95E-01	1.00E+00	1.00E+00	15	ABCA2,SLC38A5,SLC38A1,SLC24A4,ABCD2,GNG7,ATP13A1,SLC7A6,MCOLN1,SLC2A1,RHAG,SLC4A1,TFRC,SLC14A1,ATP2B1	
 1269203	Innate Immune System	8.82E-02	4.76E-01	1.00E+00	1.00E+00	21	RPS6KA5,SPTA1,TNRC6B,NR4A1,ADA2,FGL2,PTPRC,CAMK4,DUSP2,NLRP1,CNKSR2,CR1,EEF1A1,TXNIP,EEF2,CD4,IGF2R,CD44,HBB,CTSB,NCKAP1L	
 1269876	Vesicle-mediated transport	1.54E-01	5.50E-01	1.00E+00	1.00E+00	11	SPTA1,SEC16A,COL7A1,AAK1,TFRC,CD4,IGF2R,LRP1,HBA1,HBA2,HBB	
 1268854	Disease	3.21E-01	6.43E-01	1.00E+00	1.00E+00	12	RPL23A,RPL27A,RPL37,NR4A1,NOTCH2,CNKSR2,EEF2,CD4,VCAN,NEURL1,RPL13A,RPL10	
 1268677	Metabolism of proteins	5.53E-01	7.60E-01	1.00E+00	1.00E+00	19	RPL23A,RPL27A,RPL37,SPTA1,MGAT4A,NEU3,ADA2,TUBB1,YOD1,SEC16A,GNG7,KLK1,COL7A1,OGT,EEF1A1,EEF2,RPL13A,RPL10,SORL1	

PPI network construction and module analysis

PPI network complex consisted of 3648 nodes and 6305 edges, wherein node and edge represented gene and interaction between genes (Fig.3a). Moreover, CEBPD, TP73, ESR2, TAB1, MAP 3K5, FN1, UBD, RUNX1, PIK3R2 and TNF were identified as hub genes and are listed in Table 5. In addition, module analysis was conducted to detect the highly connected regions of PPI network, and two significant modules were identified (Fig.3b and Fig.3c). Further GO and pathway enrichment analysis revealed that genes in these modules were mostly implicated in regulation of ion transmembrane transport, oxoacid metabolic process, intrinsic component of plasma membrane, extracellular matrix organization and supra molecular fiber. Fig. 3 PPI network and the most significant modules of DEGs. a The PPI network of DEGs was constructed using Cytoscape b The most significant module was obtained from PPI network with 4 nodes and 6 edges for up regulated genes c The most significant module was obtained from PPI network with 6 nodes and 10 edges for down regulated genes. Up regulated genes are marked in green; down regulated genes are marked in red

Table 5 Topology table for up and down regulated genes

Regulation	Node	Degree	Betweenness	Stress	Closeness	
Up	CEBPD	114	0.046829	7961100	0.330434	
Up	TP73	111	0.034635	8777680	0.328559	
Up	ESR2	101	0.034485	6488550	0.337342	
Up	TAB1	99	0.041885	3759452	0.362813	
Up	MAP 3K5	92	0.030461	6831818	0.331998	
Up	CACNA1A	91	0.035636	5405420	0.325712	
Up	CCNA1	80	0.02152	6576136	0.326587	
Up	SLC9A3R1	77	0.024066	3777376	0.332877	
Up	SREBF1	70	0.01966	4888424	0.327673	
Up	TGM2	69	0.023349	3331196	0.360768	
Up	VAMP2	59	0.021393	4433628	0.327614	
Up	FASN	57	0.012258	2145144	0.352708	
Up	PSEN2	53	0.018322	2705190	0.32389	
Up	CKB	51	0.012369	2056678	0.335511	
Up	ALK	51	0.013768	1544390	0.292392	
Up	MED16	46	0.014057	2049900	0.326909	
Up	SLC9A3R2	45	0.013157	2184316	0.317821	
Up	APOB	43	0.012557	2206980	0.322002	
Up	MYOC	42	0.012184	1022522	0.322658	
Up	IRAK2	41	0.012813	1784830	0.321293	
Up	SLC2A4	40	0.011976	1766080	0.322601	
Up	USHBP1	36	0.015448	3575428	0.248925	
Up	MRPL11	34	0.010599	1753194	0.322287	
Up	CPLX1	33	0.009034	742112	0.287437	
Up	PACSIN1	33	0.010298	664252	0.278015	
Up	PCBD2	32	0.010339	2852002	0.275204	
Up	SLC25A10	30	0.009439	1406902	0.31647	
Up	DOT1L	29	0.007619	3660752	0.26943	
Up	CDK20	28	0.007513	1387276	0.314207	
Up	ACAT2	28	0.007324	722288	0.326091	
Up	CDKN2C	28	0.006528	1250162	0.316004	
Up	CISH	27	0.005203	494888	0.295879	
Up	GINS3	27	0.00745	1311612	0.3176	
Up	MVD	26	0.008346	1085242	0.313613	
Up	NR1I3	24	0.004449	1369088	0.285591	
Up	RAC3	23	0.005847	909650	0.317324	
Up	SETD1A	22	0.006802	741452	0.319296	
Up	GLUL	21	0.006551	455932	0.338689	
Up	NFKBIL1	20	0.007285	2695372	0.255984	
Up	CD3EAP	19	0.004472	455916	0.289697	
Up	SHANK2	19	0.00448	1859670	0.264621	
Up	GPHN	18	0.005963	580752	0.315157	
Up	PPP1R16A	17	0.006189	3748574	0.241315	
Up	CYP2E1	17	0.00535	689500	0.318654	
Up	IL12A	17	0.003913	940482	0.270248	
Up	TAF1C	16	0.004869	576732	0.316965	
Up	MPST	15	0.004427	490670	0.315703	
Up	CNTFR	15	0.004392	3618160	0.24549	
Up	DDR1	15	0.00321	479586	0.317379	
Up	MKNK2	14	0.002033	289430	0.322116	
Up	KCTD17	13	0.003492	916690	0.244208	
Up	RGS3	13	0.001735	620256	0.320982	
Up	SPHK1	13	0.002877	655002	0.317655	
Up	PRPH	13	0.003388	599412	0.319436	
Up	ADH1B	13	0.001294	370206	0.275682	
Up	SLC25A22	13	0.003141	530858	0.314776	
Up	MIB2	12	0.002205	375196	0.315185	
Up	ZNF598	12	0.004687	393930	0.312779	
Up	GK	12	0.003466	415618	0.314994	
Up	RRAD	12	0.0025	148574	0.282166	
Up	PFKFB3	12	0.001355	246878	0.314072	
Up	SPTBN4	12	0.004741	379826	0.313909	
Up	PTPN3	12	0.001814	952130	0.257957	
Up	LIN7A	11	0.004011	512222	0.31796	
Up	VPS37B	11	0.00232	329104	0.31372	
Up	TRMT1L	11	0.002348	529928	0.319184	
Up	EDNRA	11	0.001735	273128	0.314885	
Up	TBC1D7	10	0.002122	358246	0.3176	
Up	AZGP1	10	0.002218	255470	0.31337	
Up	WDR62	10	0.001673	347176	0.314912	
Up	NRXN1	10	0.003845	1972864	0.226227	
Up	CLDN5	9	0.002871	301080	0.313343	
Up	TYSND1	9	0.003301	1096284	0.204234	
Up	NEK8	9	0.001286	501688	0.317158	
Up	MICALL1	9	0.006015	346680	0.317103	
Up	TNFRSF8	8	0.001683	558578	0.221218	
Up	DDX11	8	0.002534	239432	0.313964	
Up	CRHR1	8	0.002228	518378	0.23728	
Up	QRICH2	8	0.002787	388592	0.238787	
Up	TEAD4	8	0.002413	296338	0.312993	
Up	CSPG4	8	0.001645	199988	0.313289	
Up	CABP1	8	0.001378	82156	0.281578	
Up	SULT1C2	8	0.001233	207860	0.315676	
Up	GNG7	8	0.001801	266812	0.312779	
Up	HADH	7	0.001386	314576	0.318043	
Up	EBP	7	0.002552	384196	0.317186	
Up	CSH1	7	8.48E-05	30798	0.243572	
Up	C19orf25	7	0.001712	1024492	0.232753	
Up	AASS	7	5.38E-04	163226	0.314804	
Up	POLM	6	0.001104	522630	0.201203	
Up	BSN	6	0.001531	145360	0.312457	
Up	KIFC2	6	0.001203	58718	0.27345	
Up	POMC	6	0.002233	811808	0.234609	
Up	DCXR	6	0.001279	220510	0.31658	
Up	EPHB4	6	8.00E-04	275102	0.317572	
Up	RAB26	6	0.002046	260892	0.31658	
Up	UBTD1	6	0.001963	183788	0.314586	
Up	GNG3	6	8.77E-05	19382	0.228452	
Up	SRCIN1	6	1.34E-04	36856	0.257593	
Up	DLL1	6	0.001102	106292	0.313074	
Up	IFI35	6	0.001499	178126	0.313666	
Up	EPB41L4B	6	5.42E-04	276788	0.316497	
Up	RDH13	5	0.001833	134020	0.312404	
Up	SHROOM2	5	3.34E-05	23708	0.250636	
Up	PGAM2	5	3.21E-04	99124	0.313101	
Up	RASIP1	5	0.001351	121434	0.312404	
Up	LDB3	5	5.77E-05	11670	0.240694	
Up	STBD1	5	5.68E-04	91162	0.211163	
Up	MYLPF	5	0.001107	295946	0.221057	
Up	ZNF775	5	0.00111	426814	0.230721	
Up	BOK	5	0.001655	134510	0.312404	
Up	ARHGEF15	5	0.001681	719112	0.215939	
Up	RRP1	5	6.51E-04	120052	0.314749	
Up	LLGL2	5	0.001716	131528	0.312404	
Up	PKN3	5	0.002193	149884	0.312404	
Up	AATK	5	0.001114	414048	0.231497	
Up	HELZ2	5	4.97E-04	113146	0.312752	
Up	TPRN	4	5.53E-04	316590	0.229602	
Up	PMM1	4	6.74E-04	50432	0.317324	
Up	SCN4A	4	0.001101	106362	0.254501	
Up	MIA	2	0	0	0.289951	
Up	GCAT	1	0	0	0.265816	
Up	CACNB2	1	0	0	0.241779	
Up	PWWP2B	1	0	0	0.265816	
Up	CEMP1	1	0	0	0.265816	
Down	FN1	689	0.324012	1.05E+08	0.403385	
Down	UBD	502	0.200346	87511340	0.362021	
Down	RUNX1	96	0.029748	6112420	0.328351	
Down	PIK3R2	91	0.025749	6760118	0.337529	
Down	TNF	91	0.029868	5372816	0.339382	
Down	TRIM63	88	0.033338	4601374	0.331545	
Down	FASLG	83	0.03072	3652094	0.356361	
Down	FLNC	77	0.027425	3582900	0.356257	
Down	DAB2	63	0.01646	2823298	0.354974	
Down	PRNP	61	0.022352	8130382	0.290089	
Down	RUNX2	57	0.013307	3614466	0.32323	
Down	UCHL1	54	0.013451	2855314	0.328973	
Down	MAP 1B	45	0.011916	2421086	0.323574	
Down	KRT14	44	0.006308	1848344	0.332361	
Down	DYNC1I1	41	0.009986	4398264	0.2816	
Down	UGP2	39	0.010629	2140698	0.318654	
Down	KRT5	39	0.006255	1335540	0.352742	
Down	THBS1	37	0.010831	751230	0.351315	
Down	SULT1A1	36	0.010429	1425372	0.3207	
Down	ITGAV	34	0.009907	738818	0.348595	
Down	BLNK	34	0.006063	3165890	0.267709	
Down	KRT16	34	0.004495	1291100	0.352231	
Down	TUBB2B	34	0.006677	1049214	0.327997	
Down	TPM2	31	0.005911	1029436	0.321832	
Down	SERPINE1	31	0.006739	1233976	0.3258	
Down	CSF1R	30	0.006717	1300016	0.330974	
Down	TEC	29	0.006824	858984	0.329152	
Down	UGDH	28	0.009574	1182896	0.320334	
Down	EEA1	28	0.00918	1154334	0.31573	
Down	CYBB	27	0.007148	1130954	0.315922	
Down	SNCAIP	25	0.006301	1035622	0.319856	
Down	HEXIM1	25	0.006057	1136892	0.320587	
Down	PSAT1	24	0.005926	1376392	0.324034	
Down	CASP6	23	0.005143	904188	0.326939	
Down	CCND2	23	0.004537	916146	0.317683	
Down	TFAP2C	23	0.0052	855498	0.321095	
Down	C1QA	23	0.006243	387922	0.312967	
Down	PDLIM1	22	0.005357	928252	0.314967	
Down	FAM118B	22	0.008601	929084	0.314885	
Down	MARCKS	22	0.00416	786398	0.318099	
Down	KLF10	21	0.005139	897850	0.31669	
Down	DACT1	20	0.00252	987976	0.277507	
Down	LBP	20	0.004692	404246	0.288597	
Down	AP1M2	20	0.005509	738138	0.318989	
Down	ETV1	20	0.00302	609754	0.314315	
Down	CACNA1C	19	0.004425	753630	0.318849	
Down	F2R	19	0.005228	757806	0.314586	
Down	WWC1	19	0.004648	1378328	0.261415	
Down	SPARC	19	0.002419	271042	0.288871	
Down	ETV5	19	0.006356	766338	0.321548	
Down	HLA-DRB1	18	0.004301	753340	0.315922	
Down	CD2	18	0.004823	668514	0.31658	
Down	GTF2A1L	18	0.007186	2863798	0.23688	
Down	GEM	17	0.005732	2326034	0.240583	
Down	GNG2	16	0.003555	589398	0.314126	
Down	IKBIP	16	0.004022	727254	0.319017	
Down	METTL21C	15	0.003787	493576	0.315621	
Down	ANKRD1	15	0.003619	472178	0.313774	
Down	PTPRZ1	15	0.001661	140480	0.283902	
Down	TRPV4	15	0.002549	481158	0.316662	
Down	KCNA2	15	0.00436	1061814	0.239903	
Down	ITGB1BP2	14	0.001989	240810	0.285502	
Down	FSTL1	14	0.00427	2031070	0.23759	
Down	CYP2C9	14	0.001662	302482	0.26514	
Down	MTHFD1L	14	0.002585	651008	0.31647	
Down	IQGAP2	13	0.002809	325554	0.314045	
Down	PAG1	13	0.001736	135246	0.277571	
Down	F13A1	13	0.001735	158432	0.30128	
Down	FCGR2B	13	0.001066	801788	0.251639	
Down	PALLD	13	0.003467	531744	0.313532	
Down	CD28	13	0.00323	284756	0.32323	
Down	RABIF	13	0.004967	429618	0.312832	
Down	GRB14	12	0.002983	685690	0.249385	
Down	LIMCH1	12	0.003625	2733430	0.254786	
Down	FBN1	11	0.002676	383518	0.248755	
Down	SAMSN1	11	8.53E-04	133970	0.288871	
Down	EPHB3	11	0.003278	542624	0.316607	
Down	ENC1	11	0.001583	423908	0.317324	
Down	TRIM50	11	0.00292	496854	0.312886	
Down	SERPINE2	11	0.002799	2273346	0.242664	
Down	HLA-DQA1	11	0.002544	326930	0.314369	
Down	ARRDC4	10	0.001535	375436	0.315157	
Down	RND3	10	0.00448	330498	0.313182	
Down	VLDLR	10	0.004556	320522	0.314804	
Down	SOCS5	10	0.003457	380282	0.320869	
Down	BAMBI	10	0.004199	323112	0.313909	
Down	NAIP	9	0.003621	141406	0.276246	
Down	DRD1	9	0.003299	1100044	0.229184	
Down	GLB1	9	0.002193	292422	0.314858	
Down	HGF	9	0.001854	1215984	0.238226	
Down	ALX4	9	0.003365	1011538	0.2046	
Down	COL3A1	9	5.70E-04	68058	0.284833	
Down	MTF1	9	0.002252	733044	0.272103	
Down	LOX	8	0.001541	584690	0.240345	
Down	CACNG2	8	0.002377	668336	0.245242	
Down	ANGPT2	8	8.97E-04	173688	0.314641	
Down	INHBA	8	0.001672	81898	0.210214	
Down	CCDC136	8	9.01E-04	360770	0.220509	
Down	CCL18	8	0.001487	441826	0.255876	
Down	PMEPA1	7	5.77E-04	135816	0.312967	
Down	STAB1	7	0.001896	241374	0.264544	
Down	KCNA1	7	6.54E-04	95830	0.211727	
Down	CRABP2	7	4.03E-04	99166	0.313209	
Down	PTGFRN	7	0.002199	667760	0.225681	
Down	ASAH1	7	0.001266	221440	0.315457	
Down	RCN3	7	0.00299	297670	0.314072	
Down	FRZB	7	0.002208	481180	0.22015	
Down	SLIT2	6	0.001658	181082	0.312967	
Down	CLEC4M	6	0.001712	388848	0.245111	
Down	TNFRSF12A	6	0.001027	142760	0.312671	
Down	INSM1	6	0.001234	305024	0.249044	
Down	SFRP2	6	6.16E-04	195012	0.229515	
Down	SESN1	6	4.86E-04	138422	0.313801	
Down	JAZF1	5	2.77E-04	135572	0.315922	
Down	LINGO1	5	0.001129	296570	0.207901	
Down	SLC5A1	5	5.97E-04	499752	0.26091	
Down	SERF1A	5	4.54E-04	225474	0.3168	
Down	TLR7	5	6.25E-04	167802	0.209634	
Down	AMPD1	5	5.58E-04	409250	0.245374	
Down	HPD	5	7.74E-04	98924	0.313936	
Down	ICAM5	1	0	0	0.244667	
Down	ADRA1B	1	0	0	0.262695	

Target gene – miRNA regulatory network construction and analysis

The target genes - miRNA regulatory network was constructed, including 1982 miRNAs and 245 target genes. As shown in the integrated target genes - miRNA regulatory network (Fig.4), FASN targeted 147 miRNAs (ex, hsa-mir-4314), SREBF1 targeted 81 miRNAs (ex, hsa-mir-5688), CKB targeted 72 miRNAs (ex, hsa-mir-583), CACNA1A targeted 69 miRNAs (ex, hsa-mir-632), ESR2 targeted 61 miRNAs (ex, hsa-mir-3176), MAP 1B targeted 249 miRNAs (ex, hsa-mir-1299), RUNX1 targeted 125 miRNAs (ex, hsa-mir-4530), PRNP targeted 106 miRNAs (ex, hsa-mir-4477a), FN1 targeted 105 miRNAs (ex, hsa-mir-606) and DAB2 targeted 75 miRNAs (ex, hsa-mir-1343-3p6) and are listed in Table 6. Fig. 4 Target gene - miRNA regulatory network between target genes. The blue color diamond nodes represent the key miRNAs; up regulated genes are marked in green; down regulated genes are marked in red

Table 6 miRNA - target gene and TF - target gene interaction

Regulation	Target Genes	Degree	MicroRNA	Regulation	Target Genes	Degree	TF	
Up	FASN	147	hsa-mir-4314	Up	SREBF1	94	ATF4	
Up	SREBF1	81	hsa-mir-5688	Up	FASN	71	CUX1	
Up	CKB	72	hsa-mir-583	Up	SLC9A3R1	63	MBD2	
Up	CACNA1A	69	hsa-mir-632	Up	CKB	50	IRF4	
Up	ESR2	61	hsa-mir-3176	Up	TGM2	50	SIN3A	
Up	TAB1	58	hsa-mir-4438	Up	VAMP2	32	GABPA	
Up	SLC9A3R1	56	hsa-mir-6133	Up	PSEN2	16	TGIF2	
Up	CEBPD	56	hsa-mir-4433a-3p	Up	CEBPD	15	SAP30	
Up	MAP 3K5	53	hsa-mir-4753-3p	Up	TP73	11	WRNIP1	
Up	VAMP2	39	hsa-mir-2355-5p	Up	TAB1	6	KLF9	
Up	TGM2	27	hsa-mir-375	Up	CCNA1	3	SUPT5H	
Up	TP73	22	hsa-mir-7114-3p	Up	ESR2	1	IRF1	
Up	CCNA1	19	hsa-mir-7-5p	Down	PIK3R2	73	ZNF143	
Up	PSEN2	9	hsa-mir-29b-2-5p	Down	FLNC	53	SMARCE1	
Up	ALK	6	hsa-mir-132-3p	Down	RUNX1	53	ZBTB7A	
Down	MAP 1B	249	hsa-mir-1299	Down	FN1	45	CREB1	
Down	RUNX1	125	hsa-mir-4530	Down	TRIM63	22	RELA	
Down	PRNP	106	hsa-mir-4477a	Down	TNF	20	NFIC	
Down	FN1	105	hsa-mir-606	Down	PRNP	19	KLF11	
Down	DAB2	75	hsa-mir-1343-3p	Down	MAP 1B	13	CREM	
Down	RUNX2	52	hsa-mir-944	Down	FASLG	5	BACH1	
Down	PIK3R2	48	hsa-mir-1912	Down	UBD	3	TEAD3	
Down	UCHL1	45	hsa-mir-20a-3p	Down	DYNC1I1	2	ZNF71	
Down	FLNC	35	hsa-mir-455-3p	Down	UCHL1	2	ZNF610	
Down	UBD	34	hsa-mir-214-5p	Down	RUNX2	1	NR2F6	
Down	FASLG	25	hsa-mir-7849-3p					
Down	TRIM63	24	hsa-mir-3660					
Down	TNF	15	hsa-mir-130a-3p					
Down	KRT14	11	hsa-mir-1343-3p					
Down	DYNC1I1	9	hsa-mir-129-2-3p					

Target gene-TF s regulatory network construction and analysis

The target genes -TF regulatory network was constructed, including 333 TFs and 204 target genes. As shown in the integrated target genes -TF regulatory network (Fig. 5), SREBF1 targeted 94 TFs (ex, ATF4), FASN targeted 71 TFs (ex, CUX1), SLC9A3R1 targeted 63 TFs (ex, MBD2), CKB targeted 50 TFs (ex, IRF4), TGM2 targeted 50 TFs (ex, SIN3A), PIK3R2 targeted 73 TFs (ex, ZNF143), FLNC targeted 53 TFs (ex, SMARCE1), RUNX1 targeted 53 TFs (ex, ZBTB7A), FN1 targeted 45 TFs (ex, CREB1) and TRIM63 targeted 22 TFs (ex, RELA) and are listed in Table 6. Fig. 5 Target gene - TF regulatory network between target genes. The gray color triangle nodes represent the key TFs; up regulated genes are marked in green; down regulated genes are marked in red

Receiver operating characteristic (ROC) curve analysis

The ROC curve analysis was used to assess the predictive accuracy of hub genes. AUC was determined and used to prefer the most appropriate cut-off gene expression levels. ROC curves and AUC values are presented in Fig. 6. All AUC values exceeded 0.72, while the up regulated genes CEBPD, TP73, ESR2, TAB1 and MAP 3K5, and down regulated genes FN1, UBD, RUNX1, PIK3R2 and TNF had AUC values > 0.75. Fig. 6 ROC curve analyses of hub genes. a CEBPD b TP73 c ESR2 d TAB1 e MAP 3K5 f FN1 g UBD h RUNX1 i PIK3R2 j TNF

Validation of the expression levels of candidate genes by RT-PCR

To further verify the expression level of hub genes in obese samples, RT-PCR was performed to calculate the mRNA levels of the ten hub genes identified in the present study (CEBPD, TP73, ESR2, TAB1, MAP 3K5, FN1, UBD, RUNX1, PIK3R2 and TNF) in obese samples. As illustrated in Fig. 7, the expression of CEBPD, TP73, ESR2, TAB1, MAP 3K5 were significantly up regulated in obese samples compared with normal control tissues, while FN1, UBD, RUNX1, PIK3R2 and TNF were significantly down regulated in obese samples compared with normal control tissues. The present RT-PCR results were in line with the prior bioinformatics analysis, suggesting that these hub genes might be associated with progression of obesity associated type 2 diabetes mellitus. Fig. 7 RT-PCR analyses of hub genes. A) CEBPD B) TP73C) ESR2 D) TAB1 E) MAP 3K5 F) FN1 G) UBD H) RUNX1 I) PIK3R2 J) TNF

Molecular docking studies

In the current research, the docking simulation was conducted to recognize the active site conformation and major interactions responsible for complex stability with the binding sites receptor. Drug design software Sybyl X 2.1 was used to perform docking experiments on novel molecules containing thiazolidindioneheterocyclic ring. Molecules containing the heterocyclic ring of thiazolidinedione are constructed based on the pioglitazone structure and are most widely used alone or in conjunction with other anti-diabetic drugs. Obesity associated type 2 diabetes mellitus is a chronic disorder that prevents insulin from being used by the body the way it should. It's said that people with obesity associated type 2 diabetes mellitus have insulin resistance, oral hypoglycaemic agents are used either alone or in combination of two or more drugs. Pioglitazone (Glitazones) are commonly used either alone or in combination in obesity associated type 2 diabetes mellitus. The one protein in each over expressed genes in obesity associated type 2 diabetes mellitus are selected for docking studies. The X-RAY crystallographic structure of one protein from each over-expressed genes of CEBPD, TP73, ESR2, TAB1 and MAP 3K5, and their co-crystallized PDB code of 4LY9, 2XWC, 2IOG, 5NZZ and 5UP3 respectively were selected for docking. The examinations of the designed molecules were performed to recognize the potential molecule. The foremost of the designed molecules obtained C-score greater than 6 and are said to be active. A total of 24 designed molecules few molecules have excellent good binding energy (C-score) greater than 8 respectively. Few of the designed molecules obtained good binding scores such as molecule TZP20, TZPS8, TZP22, TZPS10 (Fig.8) obtained binding core of 12.212, 11.489, 11.013 and 10.851 with 5UP3 and molecule TZP22, TZPS8, TZPS10 obtained binding score of 9.482, 9.329 and 9.252 with 2XWC and molecule TZP20, TZPS10 obtained binding score 7.359 and 6.848 with 5NZZ and molecule TZP22, TZP21, TZPS9 obtained binding score 11.053, 10.716 and 10.669 with 2IOG respectively. The molecule TZP23, TZPS5, TZPS2 obtained bind score 4.336 to 4.319 with 5NZZ and molecule TZPS10 of binding core 4.633 with 2IOG respectively. The binding score of the predicted molecules are compared with that of the standard pioglitaone obtained bind score of 10.1314, 9.834, 9.8244, 9.8284 and 7.4321 with 2IOG, 2XWC, 4LY9, 5UP3 and 5NZZ, the values are depicted in Table 7. The molecule TZP22 obtained good binding score with all proteins and hydrogen bonding and other bonding interactions with amino acids with protein code 2IOG are depicted by 3D (Fig.9) and 2D (Fig.10) figures. Fig. 8 Structures of designed molecules

Table 7 Docking results of designed molecules on over expressed proteins

Sl. No/ Code	CEBPD	TP73	ESR2	TAB1	MAP 3K5	
PDB: 4LY9	PDB:2XWC	PDB: 2IOG	PDB: 5NZZ	PDB: 5UP3	
Total Score	Crash (-Ve)	Polar	Total Score	Crash (-Ve)	Polar	Total Score	Crash (-Ve)	Polar	Total Score	Crash (-Ve)	Polar	Total Score	Crash (-Ve)	Polar	
TZPS1	6.566	-2.405	3.689	7.9803	-1.081	5.097	7.0797	-2.8787	1.281	5.0431	-0.6948	4.499	6.5667	-2.4057	3.689	
TZPS2	6.800	-1.167	3.419	6.1601	-1.083	6.357	7.8372	-2.6932	2.462	4.6726	-1.1262	1.907	6.8009	-1.1671	3.419	
TZPS3	6.468	-1.228	3.868	6.0227	-1.072	5.427	7.3618	-3.0167	1.176	4.8565	-1.1463	2.469	6.4686	-1.2285	3.868	
TZPS4	7.715	-1.553	4.079	6.9313	-0.970	3.418	6.9469	-3.4753	1.281	5.5469	-1.4023	3.550	7.7156	-1.5531	4.079	
TZPS5	6.453	-2.306	3.410	7.6894	-0.931	4.526	8.4667	-3.7554	4.692	4.3198	-1.0241	1.117	6.4536	-2.3064	3.410	
TZPS6	6.461	-1.855	3.560	6.4527	-0.984	4.601	7.4944	-2.9796	1.224	4.9436	-1.2781	2.196	6.4616	-1.8552	3.560	
TZPS7	8.534	-0.828	5.290	7.0007	-0.724	4.207	7.5843	-2.8172	1.999	4.7368	-1.3057	1.168	8.5349	-0.8288	5.290	
TZPS8	11.489	-2.122	7.200	9.3291	-0.883	7.126	8.2146	-3.2986	3.067	6.7141	-0.8055	4.503	11.4898	-2.1229	7.200	
TZPS9	7.152	-2.611	2.884	6.6449	-1.505	3.473	10.6699	-4.5053	5.965	5.0364	-1.7434	2.868	7.1521	-2.6116	2.884	
TZPS10	10.851	-1.162	8.210	9.2527	-2.282	9.981	4.6334	-5.6706	3.280	6.8487	-1.4021	5.550	10.8518	-1.1628	8.210	
TZPS11	7.549	-1.776	5.977	7.7814	-0.869	6.651	6.5663	-3.9855	2.880	5.2886	-1.4319	2.135	7.549	-1.7765	5.977	
TZPS12	6.421	-1.515	3.412	5.2317	-1.441	5.132	7.4944	-2.9796	1.224	4.9436	-1.2781	2.196	6.4616	-1.8552	3.560	
TZP13	7.906	-2.434	4.218	7.2083	-0.547	5.237	8.0517	-2.3234	2.222	4.697	-1.0273	2.204	7.9062	-2.4344	4.218	
TZP14	7.674	-3.098	4.391	7.9457	-0.894	5.848	6.2749	-3.9247	1.839	4.7119	-0.9488	1.085	7.6749	-3.0982	4.391	
TZP15	7.183	-2.936	3.636	7.1064	-0.980	4.143	8.5779	-3.6225	2.525	5.0291	-0.944	2.222	7.1835	-2.9367	3.636	
TZP16	6.406	-1.533	1.860	6.3759	-0.991	3.531	8.2194	-1.9538	2.196	4.8598	-0.9268	3.062	6.4065	-1.5333	1.860	
TZP17	8.690	-2.478	5.875	6.6083	-1.099	3.064	8.6505	-2.9891	3.094	4.948	-1.1025	3.928	8.6902	-2.4782	5.875	
TZP18	6.770	-1.638	3.659	6.8998	-0.879	4.661	7.4019	-3.3357	2.698	5.0051	-1.0824	2.177	6.7708	-1.6383	3.659	
TZP19	8.628	-1.406	5.189	8.3366	-1.139	5.462	8.8114	-4.448	5.183	4.7401	-1.8841	2.637	8.6283	-1.4062	5.189	
TZP20	12.212	-2.219	8.540	8.9043	-0.806	6.430	10.7167	-2.127	5.792	7.3594	-1.4906	5.170	12.2126	-2.2192	8.540	
TZP21	8.030	-1.557	5.434	8.2243	-1.099	6.851	8.2053	-4.0771	1.467	5.207	-1.2243	3.859	8.0309	-1.5573	5.434	
TZP22	11.013	-2.175	8.175	9.4828	-0.737	9.663	11.0511	-5.3734	6.934	5.7841	-0.7944	5.493	11.0134	-2.175	8.175	
TZP23	7.965	-3.168	6.847	8.5304	-1.107	7.803	8.0344	-2.5889	4.518	4.3368	-1.305	2.127	7.9652	-3.1688	6.847	
TZP24	6.770	-1.638	3.659	6.8998	-0.879	4.661	7.4019	-3.3357	2.698	5.0051	-1.0824	2.177	6.7708	-1.6383	3.659	
Standard Pioglitazone	9.8244	-2.396	5.097	9.834	-0.633	8.476	10.1314	-1.7567	2.8556	7.4321	-0.7906	4.505	9.8284	-2.396	5.097	

Fig. 9 3D Binding of molecule TZP22with 2IOG

Fig. 10 2D Binding of molecule TZP22with 2IOG

Discussion

Obesity associated type 2 diabetes mellitus is the most common aggressive metabolic disorder [37]. However, the most key challenge in treating obesity associated type 2 diabetes mellitus is the presence of complexity [38]. Although previous investigations have reported various potential molecular markers linked with the advancement of obesity associated type 2 diabetes mellitus, the molecular mechanism underlying its pathogenesis has not been generally studied [39]. In the present investigation, a total of 820 DEGs were identified, containing 409 up regulated genes and 411 down regulated genes. SULT1C2 [40] and UBD (ubiquitin D) [41] were responsible for progression of kidney diseases, but these genes might be liable for advancement of obesity associated type 2 diabetes mellitus. HLA-DQA1 was associated with progression of T2DM [42]. SPX (spexin hormone) [43] and APOB (apolipoprotein B) [44] are a critical proteins plays an important role in obesity associated type 2 diabetes mellitus.

The GO and pathway enrichment analysis of DEG are closely related to obesity associated type 2 diabetes mellitus. Genes such as KCNE5 [45], SHANK3 [46], CASQ2 [47], EDNRA (endothelin receptor type A) [48], EPHB4 [49], ALPK3 [50], WNT11 [51], IRAK2 [52], FBN1 [53], SFRP2 [54], CLCA2 [55], NEXN (nexilin F-actin binding protein) [56], PALLD (palladin, cytoskeletal associated protein) [57], DAB2 [58], NRP2 [59], THBS2 [60], CSF1R [61], KCNA2 [62], CACNA1C [63], F2R [64], UCHL1 [65], CCL18 [66], ITGB1BP2 [67] and FMOD (fibromodulin) [68] were reportedly involved in cardio vascular diseases, but these genes might be key for progression of obesity associated type 2 diabetes mellitus. Hu et al. [69], Liu et al. [70], Eltokhi et al. [71], Cai et al. [72], Pfeiffer et al. [73], Lin et al. [74], Royer-Zemmour et al. [75], Pastor et al. [76], Goodspeed et al. [77], Zhang et al. [78], Rogers et al. [79], Su et al. [80] and Foale et al. [81] reported that NRXN1, CRHR1, SHANK2, PSEN2, CKB (creatine kinase B), CD200R1, SRPX2, PTPRZ1, SLC6A1, GABRB2, KCNA1, ASAH1 and LINGO1 were the genes expressed in progression of neuropsychiatric disorders, but these genes might be involved in advancement of obesity associated type 2 diabetes mellitus. Reports indicate that genes include SPHK2 [82], NPC1L1 [83], CNTFR (ciliaryneurotrophic factor receptor) [84], SLC2A4 [85], EDA (ectodysplasin A) [86], TGM2 [87], GCK (glucokinase) [88], FASN (fatty acid synthase) [89], FAP (fibroblast activation protein alpha) [90], PRNP (prion protein) [91], LYVE1 [92], SERPINE1 [93], TNF (tumor necrosis factor) [94], FASLG (Fas ligand) [95], HGF (hepatocyte growth factor) [96], FNDC5 [97], LBP (lipopolysaccharide binding protein) [98] and LOX (lysyl oxidase) [99] were the genes expressed in obesity associated type 2 diabetes mellitus. Hirai et al [100], Vuori et al [101], Porta et al [102], Nomoto et al [103] and Blindbæk et al [104] demonstrates that VAMP2, CACNB2, SLC19A3, PFKFB3 and MFAP4 were the genes essential for progression of type 1 diabetes, but these genes might be key for advancement of obesity associated type 2 diabetes mellitus. Genes such as CACNA1A [105], ALK (ALK receptor tyrosine kinase) [106], SLC4A4 [107], STOX1 [108], COL3A1 [109], VNN1 [110], SLC4A7 [111], BDKRB2 [112], DRD1 [113] and LPAR1 [114] have reported significantly linked with hypertension, but these genes might be crucial for progression of obesity associated type 2 diabetes mellitus. Genes such as KCNE2 [115], DLL1 [116], ACVR1C [117], RGS3 [118], MLXIPL (MLX interacting protein like) [119], PAG1 [120], SLC2A10 [121] and GRB14 [122] play important role in type 2 diabetes mellitus progression. A recent investigation has indicated that genes such as GPIHBP1 [123], FGFRL1 [124], DAPK2 [125], MAP 3K5 [126], ANKK1 [127], GK (glycerol kinase) [128], SPHK1 [129], GNG3 [130], FSTL3 [131], SLIT2 [132], CCDC80 [133], RND3 [134], PTGER4 [135], RUNX1 [136], ADAM12 [137], OLR1 [138], THBS1 [139], CD28 [140], TRPV4 [141], ATRN (attractin) [142], MRC1 [143], SEMA3C [144], HTR2B [145], NOX4 [146], TACR1 [147], BAMBI [148], PDGFD (platelet derived growth factor D) [149], APLN (apelin) [150], MFAP5 [151] and LUM (lumican) [152] are associated with a development of obesity. A previous investigation found that genes such asDDR1 [153], TAB1 [154], NEK8 [155], SERPINE2 [156], FCGR2B [157], ANGPT2 [158], FN1 [159], SOCS5 [158], SMOC2 [160], CD2 [161] and SCN9A [162] expression were associated with a kidney diseases, but these genes might be responsible for advancement of obesity associated type 2 diabetes mellitus.

In addition, an investigation reported that hub genes serve an essential role in maintaining the entire PPI network and its modules are indispensable. 10 hub genes, including CEBPD, TP73, ESR2, TAB1, MAP 3K5, FN1, UBD, RUNX1, PIK3R2 and TNF, were identified as the key genes responsible for progression of obesity associated type 2 diabetes mellitus. Investigation has demonstrated that CEBPD (CCAAT enhancer binding protein delta) is involved in obesity [163]. An investigation by Domingues-Montanari et al. [164] demonstrated that key gene ESR2 was involved in the progression of cardio vascular disease, but this gene might be responsible for progression of obesity associated type 2 diabetes mellitus. TP73, PIK3R2, SLC9A3R1, KRT5, KRT14 and TFAP2C are novel biomarkers for pathogenesis of obesity associated type 2 diabetes mellitus.

The miRNA-target gene regulatory network and TF-target gene regulatory network highlighted in the current investigation provides new theoretical guidance for further exploring the molecular mechanism of obesity associated type 2 diabetes mellitus and provides a new perspective for understanding the underlying biological processes of this diseases, and miRNA and TF targeted therapy. Eberlé et al [165], Cheng et al [166], Cavallari et al [167], Qi et al [168] and Yan et al [169] indicated that SREBF1, MBD2, IRF4, CREB1 and RELA (Nuclear factor-kB) were the genes responsible for advancement of obesity associated type 2 diabetes mellitus. Matsha et al [170] and Ding et al [171] demonstrated that hsa-mir-1299 and hsa-mir-4530 were the miRNAs liable for progression of type 2 diabetes mellitus. Hall et al [172] and Salazar-Mendiguchía et al [173] reported that FLNC (filamin C) and TRIM63 were the genes involved in progression of cardio vascular disease, but these genes might be essential for development of obesity associated type 2 diabetes mellitus. Xiao et al [174], Stratigopoulos et al [175] and Zhou et al [176] noted that ATF4, CUX1 and ZBTB7A were the genes responsible for advancement of obesity. MAP 1B, hsa-mir-4314, hsa-mir-5688, hsa-mir-583, hsa-mir-632, hsa-mir-3176, hsa-mir-4477a, hsa-mir-606, hsa-mir-1343-3p6, SIN3A, ZNF143 and SMARCE1 are the novel biomarkers for pathogenesis of obesity associated type 2 diabetes mellitus.

However, this investigation had distinct limitations. First, the mechanisms of several hub genes in the pathological process of obesity associated type 2 diabetes mellitus remain unclear, permit further investigation. Moreover, the potency of our small molecule drug screening in diminishing side effects remains to be assessed.

In conclusion, with the integrated bioinformatics analysis for expression profiling by high throughput sequencing in obesity associated type 2 diabetes mellitus, ten hub genes associated with the pathogenesis and prognosis of obesity associated type 2 diabetes, including CEBPD, TP73, ESR2, TAB1, MAP 3K5, FN1, UBD, RUNX1, PIK3R2 and TNF. These hub genes were associated with progression of obesity associated type 2 diabetes mellitus and first five (CEBPD, TP73, ESR2, TAB1 and MAP 3K5) of them might be linked with targeted therapy. These hub genes might be regarded as new diagnostic and prognostic biomarkers for obesity associated type 2 diabetes mellitus. However, further in-depth investigation (in vivo and in vitro experiment) is necessary to elucidate the biological function of these genes in obesity associated type 2 diabetes mellitus.

Acknowledgements

I thank Jun Yoshino, Washington University School of Medicine, Medicine, St. Louis, USA, very much, the author who deposited their profiling by high throughput sequencing dataset, GSE143319, into the public GEO database.

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

No informed consent because this study does not contain human or animals participants.

Authors’ contributions

P. G - Methodology and validation. B. V - Writing original draft, and review and editing. A. T - Formal analysis and validation. C. V - Software and investigation. I. K - Supervision and resources. The authors read and approved the final manuscript.

Availability of data and materials

The datasets supporting the conclusions of this article are available in the GEO (Gene Expression Omnibus) (https://www.ncbi.nlm.nih.gov/geo/) repository. [(GSE143319) (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE143319]

Declarations

Ethics approval and consent to participate

This article does not contain any studies with human participants or animals performed by any of the authors.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Pulgaron ER Delamater AM Obesity and type 2 diabetes in children: epidemiology and treatment Curr Diab Rep. 2014 14 8 508 10.1007/s11892-014-0508-y 24919749
2. Taylor R Type 2 diabetes: etiology and reversibility Diab Care. 2013 36 4 1047 1055 10.2337/dc12-1805
3. Catalán V Gómez-Ambrosi J Rodríguez A Ramírez B Rotellar F Valentí V Silva C Gil MJ Salvador J Frühbeck G Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass J Clin Endocrinol Metab. 2011 96 1 200 209 10.1210/jc.2010-0994 20943784
4. Fukushima A Lopaschuk GD Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure Biochim Biophys Acta. 2016 1862 12 2211 2220 10.1016/j.bbadis.2016.07.020 27479696
5. Pugazhenthi S Qin L Reddy PH Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease Biochim Biophys Acta Mol Basis Dis. 2017 1863 5 1037 1045 10.1016/j.bbadis.2016.04.017 27156888
6. Chagnac A Zingerman B Rozen-Zvi B Herman-Edelstein M Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity Nephron. 2019 143 1 38 42 10.1159/000499486 30947190
7. Cheung N Wong TY Obesity and eye diseases Surv Ophthalmol. 2007 52 2 180 195 10.1016/j.survophthal.2006.12.003 17355856
8. Temelkova-Kurktschiev T Stefanov T Lifestyle and genetics in obesity and type 2 diabetes Exp Clin Endocrinol Diabetes. 2012 120 1 1 6 10.1055/s-0031-1285832 21915815
9. Wen X Qian C Zhang Y Wu R Lu L Zhu C Cheng X Cui R You H Mei F Key pathway and gene alterations in the gastric mucosa associated with obesity and obesity-related diabetes J Cell Biochem. 2019 120 4 6763 6771 10.1002/jcb.27976 30450618
10. Kruse R Vienberg SG Vind BF Andersen B Højlund K Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes Diabetologia. 2017 60 10 2042 2051 10.1007/s00125-017-4373-5 28721439
11. Davison LJ Holder A Catchpole B O'Callaghan CA The Canine POMC Gene, Obesity in Labrador Retrievers and Susceptibility to Diabetes Mellitus J Vet Intern Med. 2017 31 2 343 348 10.1111/jvim.14636 28176381
12. Huang X Liu G Guo J Su Z The PI3K/AKT pathway in obesity and type 2 diabetes Int J Biol Sci. 2018 14 11 1483 1496 10.7150/ijbs.27173 30263000
13. Gurzov EN Stanley WJ Pappas EG Thomas HE Gough DJ The JAK/STAT pathway in obesity and diabetes FEBS J. 2016 283 16 3002 3015 10.1111/febs.13709 26972840
14. Xin Y Kim J Okamoto H Ni M Wei Y Adler C Murphy AJ Yancopoulos GD Lin C Gromada J RNA Sequencing of Single Human Islet Cells Reveals Type 2 Diabetes Genes Cell Metab. 2016 24 4 608 615 10.1016/j.cmet.2016.08.018 27667665
15. Clough E Barrett T The Gene Expression Omnibus Database Methods Mol Biol. 2016 1418 93 110 10.1007/978-1-4939-3578-9_5 27008011
16. Ding X Iyer R Novotny C Metzger D Zhou HH Smith GI Yoshino M Yoshino J Klein S Swaminath G Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction Sci Rep. 2020 10 1 3417 10.1038/s41598-020-60290-1 32099031
17. Ritchie ME Phipson B Wu D Hu Y Law CW Shi W Smyth GK Limma powers differential expression analyses for RNA-sequencing and microarray studies Nucleic Acids Res 2015 43 7 e47 10.1093/nar/gkv007 25605792
18. Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009; 37(Web Server issue):W305-W311. doi:10.1093/nar/gkp427
19. Thomas PD The Gene Ontology and the Meaning of Biological Function Methods Mol Biol. 2017 1446 15 24 10.1007/978-1-4939-3743-1_2 27812932
20. Fabregat A Jupe S Matthews L Sidiropoulos K Gillespie M Garapati P Haw R Jassal B Korninger F May B The Reactome Pathway Knowledgebase Nucleic Acids Res. 2018 46 D1 D649 D655 10.1093/nar/gkx1132 29145629
21. Orchard S Kerrien S Abbani S Aranda B Bhate J Bidwell S Bridge A Briganti L Brinkman FS Cesareni G Protein interaction data curation: the International Molecular Exchange (IMEx) consortium Nat Methods. 2012 9 4 345 350 10.1038/nmeth.1931 22453911
22. Shannon P Markiel A Ozier O Baliga NS Wang JT Ramage D Amin N Schwikowski B Ideker T Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res 2003 13 11 2498 2504 10.1101/gr.1239303 14597658
23. Przulj N Wigle DA Jurisica I Functional topology in a network of protein interactions Bioinformatics. 2004 20 3 340 348 10.1093/bioinformatics/btg415 14960460
24. Nguyen TP, Liu WC, Jordán F. Inferring pleiotropy by network analysis: linked diseases in the human PPI network. BMC Syst Biol. 2011; 5:179. Published 2011 Oct 31. doi: 10.1186/1752-0509-5-179
25. Shi Z Zhang B Fast network centrality analysis using GPUs BMC Bioinformatics. 2011 12 149 10.1186/1471-2105-12-149 21569426
26. Fadhal E Gamieldien J Mwambene EC Protein interaction networks as metric spaces: a novel perspective on distribution of hubs BMC Syst Biol. 2014 8 6 10.1186/1752-0509-8-6 24438364
27. Zaki N Efimov D Berengueres J Protein complex detection using interaction reliability assessment and weighted clustering coefficient BMC Bioinform 2013 14 163 10.1186/1471-2105-14
28. Fan Y Xia J miRNet-Functional Analysis and Visual Exploration of miRNA-Target Interactions in a Network Context Methods Mol Biol 2018 1819 215 233 10.1007/978-1-4939-8618-7_10 30421406
29. Zhou G Soufan O Ewald J Hancock REW Basu N Xia J NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis Nucleic Acids Res 2019 47 W234 W241 10.1093/nar/gkz240 30931480
30. Robin X Turck N Hainard A Tiberti N Lisacek F Sanchez JC Müller M pROC: an open-source package for R and S+ to analyze and compare ROC curves BMC Bioinform 2011 12 77 10.1186/1471-2105-12-77
31. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods. 2001 25 4 402 408 10.1006/meth.2001 11846609
32. Naim MJ Alam O Alam MJ Hassan MQ Siddiqui N Naidu VGM Alam MI Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents Bioorg Chem. 2018 76 98 112 10.1016/j.bioorg.2017.11.010 29169079
33. Mohammadi-Khanaposhtani M Rezaei S Khalifeh R Imanparast S Faramarzi MA Bahadorikhalili S Safavi M Bandarian F Nasli Esfahani E Mahdavi M Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes Bioorg Chem. 2018 80 288 295 10.1016/j.bioorg.2018.06.035 29980114
34. Rojas LB Gomes MB Metformin: an old but still the best treatment for type 2 diabetes Diabetol Metab Syndr. 2013 5 1 6 10.1186/1758-5996-5-6 23415113
35. Thakral S Narang R Kumar M Singh V Synthesis, molecular docking and molecular dynamic simulation studies of 2-chloro-5-[(4-chlorophenyl) sulfamoyl]-N-(alkyl/aryl)-4-nitrobenzamide derivatives as antidiabetic agents BMC Chem 2020 14 1 1 6 10.1186/s13065-020-00703-4 31922150
36. Srikanth Kumar K Lakshmana Rao A Basaveswara Rao MV Design, synthesis, biological evaluation and molecular docking studies of novel 3-substituted-5-[(indol-3-yl)methylene]-thiazolidine-2,4-dione derivatives Heliyon. 2018 4 9 e00807 10.1016/j.heliyon.2018.e00807 30258996
37. Mohammad S Ahmad J Management of obesity in patients with type 2 diabetes mellitus in primary care Diab Metab Syndr. 2016 10 3 171 181 10.1016/j.dsx.2016.01.017
38. Rao M, Gao C, Xu L, Jiang L, Zhu J, Chen G, Law BYK, Xu Y. Effect of Inulin-Type Carbohydrates on Insulin Resistance in Patients with Type 2 Diabetes and Obesity: A Systematic Review and Meta-Analysis. J Diab Res. 2019:5101423. 10.1155/2019/5101423.
39. Al-Sulaiti H Diboun I Agha MV Metabolic signature of obesity-associated insulin resistance and type 2 diabetes J Transl Med. 2019 17 1 348 10.1186/s12967-019-2096-8 31640727
40. Sugimura K Tanaka T Tanaka Y Takano H Kanagawa K Sakamoto N Ikemoto S Kawashima H Nakatani T Decreased sulfotransferase SULT1C2 gene expression in DPT-induced polycystic kidney Kidney Int. 2002 62 3 757 762 10.1046/j.1523-1755.2002.00512.x 12164856
41. Zhang JY Wang M Tian L Genovese G Yan P Wilson JG Thadhani R Mottl AK Appel GB Bick AG UBD modifies APOL1-induced kidney disease risk Proc Natl Acad Sci U S A. 2018 115 13 3446 3451 10.1073/pnas.1716113115 29531077
42. Ma ZJ Sun P Guo G Zhang R Chen LM Association of the HLA-DQA1 and HLA-DQB1 Alleles in Type 2 Diabetes Mellitus and Diabetic Nephropathy in the Han Ethnicity of China J Diab Res. 2013 2013 452537 10.1155/2013/452537
43. Kołodziejski PA Pruszyńska-Oszmałek E Korek E Sassek M Szczepankiewicz D Kaczmarek P Nogowski L Maćkowiak P Nowak KW Krauss H Serum levels of spexin and kisspeptin negatively correlate with obesity and insulin resistance in women Physiol Res 2018 67 1 45 56 10.33549/physiolres.933467 29137471
44. Onat A Can G Hergenç G Yazici M Karabulut A Albayrak S Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation Int J Obes (Lond). 2007 31 7 1119 1125 10.1038/sj.ijo.0803552 17299378
45. Ravn LS Hofman-Bang J Dixen U Larsen SO Jensen G Haunsø S Svendsen JH Christiansen M Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation Am J Cardiol. 2005 96 3 405 407 10.1016/j.amjcard.2005.03.086 16054468
46. Man W Gu J Wang B Zhang M Hu J Lin J Sun D Xiong Z Gu X Hao K SHANK3 Co-ordinately Regulates Autophagy and Apoptosis in Myocardial Infarction Front Physiol. 2020 11 1082 10.3389/fphys.2020.01082 32982797
47. Refaat MM Aouizerat BE Pullinger CR Malloy M Kane J Tseng ZH Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease Heart Rhythm. 2014 11 4 646 652 10.1016/j.hrthm.2014.01.015 24444446
48. Pritchard AB Kanai SM Krock B Schindewolf E Oliver-Krasinski J Khalek N Okashah N Lambert NA Tavares ALP Zackai E Loss-of-function of Endothelin receptor type A results in Oro-Oto-Cardiac syndrome Am J Med Genet A. 2020 182 5 1104 1116 10.1002/ajmg.a.61531 32133772
49. Yang D Jin C Ma H Huang M Shi GP Wang J Xiang M EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease Angiogenesis. 2016 19 3 297 309 10.1007/s10456-016-9514-9 27216867
50. Jorholt J Formicheva Y Vershinina T Kiselev A Muravyev A Demchenko E Fedotov P Zlotina A Rygkov A Vasichkina E Cardiomyopathy and Skeletal Muscle Features Associated with ALPK3 Homozygous and Compound Heterozygous Variants Genes (Basel). 2020 11 10 1201 10.3390/genes11101201
51. Touma M Kang X Gao F Zhao Y Cass AA Biniwale R Xiao X Eghbali M Coppola G Reemtsen B Wnt11 regulates cardiac chamber development and disease during perinatal maturation JCI Insight. 2017 2 17 e94904 10.1172/jci.insight.94904
52. Liu Z Zhao N Zhu H Zhu S Pan S Xu J Zhang X Zhang Y Wang J Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2 Cardiovasc Diabetol. 2015 14 125 10.1186/s12933-015-0288-y 26394923
53. Barrett PM Topol EJ The fibrillin-1 gene: unlocking new therapeutic pathways in cardiovascular disease Heart. 2013 99 2 83 90 10.1136/heartjnl-2012-301840 22942299
54. Wu Y Liu X Zheng H Zhu H Mai W Huang X Huang Y Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease Int J Biol Sci. 2020 16 5 730 738 10.7150/ijbs.40923 32071544
55. Mao Z Wang Y Peng H He F Zhu L Huang H Huang X Lu X Tan X A newly identified missense mutation in CLCA2 is associated with autosomal dominant cardiac conduction block Gene. 2019 714 143990 10.1016/j.gene.2019.143990 31326550
56. Wu C Yan H Sun J Yang F Song C Jiang F Li Y Dong J Zheng GY Tian XL NEXN is a novel susceptibility gene for coronary artery disease in Han Chinese PLoS One. 2013 8 12 e82135 10.1371/journal.pone.0082135 24349201
57. Hoke M Schillinger M Dick P Exner M Koppensteiner R Minar E Mlekusch W Schlager O Wagner O Mannhalter C Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosis Eur J Clin Invest. 2011 41 4 365 371 10.1111/j.1365-2362.2010.02416.x 21054356
58. Wang Y Wang Y Adi D He X Liu F Abudesimu A Fu Z Ma Y Dab2 gene variant is associated with increased coronary artery disease risk in Chinese Han population Medicine (Baltimore). 2020 99 27 e20924 10.1097/MD.0000000000020924 32629690
59. Harman JL Sayers J Chapman C Pellet-Many C Emerging Roles for Neuropilin-2 in Cardiovascular Disease Int J Mol Sci. 2020 21 14 5154 10.3390/ijms21145154
60. Wang Y Fu W Xie F Wang Y Chu X Wang H Shen M Wang Y Wang Y Sun WL Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population J Hum Genet. 2010 55 8 490 494 10.1038/jhg.2010.53 20485444
61. Wei Y Zhu M Corbalán-Campos J Heyll K Weber C Schober A Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis Arterioscler Thromb Vasc Biol. 2015 35 4 796 803 10.1161/ATVBAHA.114.304723 25810298
62. Long QQ Wang H Gao W Fan Y Li YF Ma Y Yang Y Shi HJ Chen BR Meng HY Long Noncoding RNA Kcna2 Antisense RNA Contributes to Ventricular Arrhythmias via Silencing Kcna2 in Rats With Congestive Heart Failure J Am Heart Assoc 2017 6 12 e005965 10.1161/JAHA.117.005965 29263036
63. Beitelshees AL Navare H Wang D Gong Y Wessel J Moss JI Langaee TY Cooper-DeHoff RM Sadee W Pepine CJ CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response Circ Cardiovasc Genet. 2009 2 4 362 370 10.1161/CIRCGENETICS.109.857839 20031608
64. Gigante B Vikström M Meuzelaar LS Chernogubova E Silveira A Hooft FV Hamsten A de Faire U Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels Thromb Haemost. 2009 101 5 943 953 10.1160/TH08-09-0612 19404549
65. Lei Q Yi T Li H Yan Z Lv Z Li G Wang Y Ubiquitin C-terminal hydrolase L1 (UCHL1) regulates post-myocardial infarction cardiac fibrosis through glucose-regulated protein of 78 kDa (GRP78) Sci Rep. 2020 10 1 10604 10.1038/s41598-020-67746-4 32606430
66. de Jager SC Bongaerts BW Weber M Kraaijeveld AO Rousch M Dimmeler S van Dieijen-Visser MP Cleutjens KB Nelemans PJ van Berkel TJ Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes PLoS One. 2012 7 9 e45804 10.1371/journal.pone.0045804 23029252
67. Ruppert V Meyer T Richter A Maisch B Pankuweit S German Competence Network of Heart Failure. Identification of a missense mutation in the melusin-encoding ITGB1BP2 gene in a patient with dilated cardiomyopathy Gene. 2013 512 2 206 210 10.1016/j.gene.2012.10.055 23124043
68. Andenæs K Lunde IG Mohammadzadeh N Dahl CP Aronsen JM Strand ME Palmero S Sjaastad I Christensen G Engebretsen KVT The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling PLoS One. 2018 13 7 e0201422 10.1371/journal.pone.0201422 30052659
69. Hu Z Xiao X Zhang Z Li M Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders Mol Psychiatr 2019 24 10 1400 1414 10.1038/s41380-019-0438-9
70. Liu Z Liu W Yao L Yang C Xiao L Wan Q Gao K Wang H Zhu F Wang G Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder Sci Rep. 2013 3 1548 10.1038/srep01548 23529111
71. Eltokhi A Rappold G Sprengel R Distinct Phenotypes of Shank2 Mouse Models Reflect Neuropsychiatric Spectrum Disorders of Human Patients With SHANK2 Variants Front Mol Neurosci. 2018 11 240 10.3389/fnmol.2018.00240 30072871
72. Cai Y An SS Kim S Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders Clin Interv Aging. 2015 10 1163 1172 10.2147/CIA.S85808 26203236
73. Pfeiffer FE Homburger HA Houser OW Baker HL Jr Yanagihara T Elevation of serum creatine kinase B-subunit levels by radiographic contrast agents in patients with neurologic disorders Mayo Clin Proc. 1987 62 5 351 357 10.1016/s0025-6196(12)65438-x 3573823
74. Lin S He L Shen R Fang F Pan H Zhu X Wang M Zhou Z Liu Z Wang X Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson's disease Eur J Neurol. 2020 27 7 1224 1230 10.1111/ene.14224 32190938
75. Royer-Zemmour B Ponsole-Lenfant M Gara H Roll P Lévêque C Massacrier A Ferracci G Cillario J Robaglia-Schlupp A Vincentelli R Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR Hum Mol Genet. 2008 17 23 3617 3630 10.1093/hmg/ddn256 18718938
76. Pastor M Fernández-Calle R Di Geronimo B Vicente-Rodríguez M Zapico JM Gramage E Coderch C Pérez-García C Lasek AW Puchades-Carrasco L Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders Eur J Med Chem. 2018 144 318 329 10.1016/j.ejmech.2017.11.080 29275231
77. Goodspeed K Pérez-Palma E Iqbal S Cooper D Scimemi A Johannesen KM Stefanski A Demarest S Helbig KL Kang J Current knowledge of SLC6A1-related neurodevelopmental disorders Brain Commun 2020 2 fcaa170 10.1093/braincomms/fcaa170 33241211
78. Zhang T Li J Yu H Shi Y Li Z Wang L Wang Z Lu T Wang L Yue W Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium PLoS One. 2018 13 6 e0198690 10.1371/journal.pone.0198690 29894498
79. Rogers A Golumbek P Cellini E Doccini V Guerrini R Wallgren-Pettersson C Thuresson AC Gurnett CA De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants Am J Med Genet A. 2018 176 8 1748 1752 10.1002/ajmg.a.38840 30055040
80. Su Y Yang L Li Z Wang W Xing M Fang Y Cheng Y Lin GN Cui D The interaction of ASAH1 and NGF gene involving in neurotrophin signaling pathway contributes to schizophrenia susceptibility and psychopathology Prog Neuropsychopharmacol Biol Psychiatry. 2021 104 110015 10.1016/j.pnpbp.2020.110015 32569620
81. Foale S Berry M Logan A Fulton D Ahmed Z LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders? Neural Regen Res. 2017 12 8 1247 1251 10.4103/1673-5374.213538 28966634
82. Ravichandran S Finlin BS Kern PA Özcan S Sphk2-/- mice are protected from obesity and insulin resistance Biochim Biophys Acta Mol Basis Dis. 2019 1865 3 570 576 10.1016/j.bbadis.2018.12.012 30593892
83. Labonté ED Camarota LM Rojas JC Jandacek RJ Gilham DE Davies JP Ioannou YA Tso P Hui DY Howles PN Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice Am J Physiol Gastrointest Liver Physiol. 2008 295 4 G776 G783 10.1152/ajpgi.90275.2008 18718999
84. Watt MJ Dzamko N Thomas WG Rose-John S Ernst M Carling D Kemp BE Febbraio MA Steinberg GR CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK Nat Med. 2006 12 5 541 548 10.1038/nm1383 16604088
85. Yang Q Graham TE Mody N Preitner F Peroni OD Zabolotny JM Kotani K Quadro L Kahn BB Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature. 2005 436 7049 356 362 10.1038/nature03711 16034410
86. Awazawa M Gabel P Tsaousidou E Nolte H Krüger M Schmitz J Ackermann PJ Brandt C Altmüller J Motameny S A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle Nat Med. 2017 23 12 1466 1473 10.1038/nm.4420 29106399
87. Ludvigsen TP Olsen LH Pedersen HD Christoffersen BØ Jensen LJ Hyperglycemia-induced transcriptional regulation of ROCK1 and TGM2 expression is involved in small artery remodeling in obese diabetic Göttingen Minipigs Clin Sci (Lond). 2019 133 24 2499 2516 10.1042/CS20191066 31830262
88. Cockburn BN Ostrega DM Sturis J Kubstrup C Polonsky KS Bell GI Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes Diabetes. 1997 46 9 1434 1439 10.2337/diab.46.9.1434 9287043
89. Berndt J Kovacs P Ruschke K Klöting N Fasshauer M Schön MR Körner A Stumvoll M Blüher M Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes Diabetologia. 2007 50 7 1472 1480 10.1007/s00125-007-0689-x 17492427
90. Williams KH Viera de Ribeiro AJ Prakoso E Veillard AS Shackel NA Bu Y Brooks B Cavanagh E Raleigh J Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity Diab Res Clin Pract. 2015 108 3 466 472 10.1016/j.diabres.2015.02.024
91. de Brito G Lupinacci FC Beraldo FH Santos TG Roffé M Lopes MH de Lima VC Martins VR Hajj GN Loss of prion protein is associated with the development of insulin resistance and obesity Biochem J. 2017 474 17 2981 2991 10.1042/BCJ20170137 28739602
92. Michurina SV Ishchenko IY Arkhipov SA Klimontov VV Rachkovskaya LN Konenkov VI Zavyalov EL Effects of Melatonin, Aluminum Oxide, and Polymethylsiloxane Complex on the Expression of LYVE-1 in the Liver of Mice with Obesity and Type 2 Diabetes Mellitus Bull Exp Biol Med. 2016 162 2 269 272 10.1007/s10517-016-3592-y 27909960
93. Kaur P Reis MD Couchman GR Forjuoh SN Greene JF Asea A SERPINE 1 Links Obesity and Diabetes: A Pilot Study J Proteomics Bioinform. 2010 3 6 191 199 10.4172/jpb.1000139 21113241
94. Serino M Menghini R Fiorentino L Amoruso R Mauriello A Lauro D Sbraccia P Hribal ML Lauro R Federici M Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes Diabetes. 2007 56 10 2541 2546 10.2337/db07-0360 17646208
95. Blüher M Klöting N Wueest S Schoenle EJ Schön MR Dietrich A Fasshauer M Stumvoll M Konrad D Fas and FasL expression in human adipose tissue is related to obesity, insulin resistance, and type 2 diabetes J Clin Endocrinol Metab. 2014 99 1 E36 E44 10.1210/jc.2013-2488 24178789
96. Muratsu J Iwabayashi M Sanada F Taniyama Y Otsu R Rakugi H Morishita R Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice Sci Rep. 2017 7 1 130 10.1038/s41598-017-00199-4 28273932
97. Xiong XQ Geng Z Zhou B Zhang F Han Y Zhou YB Wang JJ Gao XY Chen Q Li YH FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity Metabolism. 2018 83 31 41 10.1016/j.metabol.2018.01.013 29374559
98. Kim KE Cho YS Baek KS Li L Baek KH Kim JH Kim HS Sheen YH Lipopolysaccharide-binding protein plasma levels as a biomarker of obesity-related insulin resistance in adolescents Korean J Pediatr. 2016 59 5 231 238 10.3345/kjp.2016.59.5.231 27279888
99. Daley EJ Pajevic PD Roy S Trackman PC Impaired Gastric Hormone Regulation of Osteoblasts and Lysyl Oxidase Drives Bone Disease in Diabetes Mellitus JBMR Plus. 2019 3 10 e10212 10.1002/jbm4.10212 31687648
100. Hirai H Miura J Hu Y Larsson H Larsson K Lernmark A Ivarsson SA Wu T Kingman A Tzioufas AG Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens Clin Immunol. 2008 127 3 366 374 10.1016/j.clim.2008.01.018 18359275
101. Vuori N Sandholm N Kumar A Hietala K Syreeni A Forsblom C Juuti-Uusitalo K Skottman H Imamura M Maeda S CACNB2 Is a Novel Susceptibility Gene for Diabetic Retinopathy in Type 1 Diabetes Diabetes. 2019 68 11 2165 2174 10.2337/db19-0130 31439644
102. Porta M Toppila I Sandholm N Hosseini SM Forsblom C Hietala K Borio L Harjutsalo V Klein BE Klein R Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes Diabetes. 2016 65 4 1022 1030 10.2337/db15-1247 26718501
103. Nomoto H Pei L Montemurro C Rosenberger M Furterer A Coppola G Nadel B Pellegrini M Gurlo T Butler PC Activation of the HIF1α/PFKFB3 stress response pathway in beta cells in type 1 diabetes Diabetologia. 2020 63 1 149 161 10.1007/s00125-019-05030-5 31720731
104. Blindbæk SL Schlosser A Green A Holmskov U Sorensen GL Grauslund J Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus Acta Diabetol. 2017 54 4 367 372 10.1007/s00592-016-0953-y 28039584
105. Hu Z Liu F Li M He J Huang J Rao DC Hixson JE Gu C Kelly TN Chen S Associations of Variants in the CACNA1A and CACNA1C Genes With Longitudinal Blood Pressure Changes and Hypertension Incidence: The GenSalt Study Am J Hypertens. 2016 29 11 1301 1306 10.1093/ajh/hpw070 27418245
106. Tabbò F D'Aveni A Tota D Pignataro D Bironzo P Carnio S Cappia S Cortese G Righi L Novello S Pulmonary Arterial Hypertension in ALK Receptor Tyrosine Kinase-Positive Lung Cancer Patient: Adverse Event or Disease Spread? J Thorac Oncol. 2019 14 2 e38 e40 10.1016/j.jtho.2018.10.154 30683298
107. Yang HC Liang YJ Chen JW Chiang KM Chung CM Ho HY Ting CT Lin TH Sheu SH Tsai WC Identification of IGF1, SLC4A4, WWOX, and SFMBT1 as hypertension susceptibility genes in Han Chinese with a genome-wide gene-based association study PLoS One. 2012 7 3 e32907 10.1371/journal.pone.0032907 22479346
108. Erlandsson L Ducat A Castille J Zia I Kalapotharakos G Hedström E Vilotte JL Vaiman D Hansson SR lpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model Sci Rep 2019 9 1 8561 10.1038/s41598-019-44639-9 31189914
109. Samokhin AO Stephens T Wertheim BM Wang RS Vargas SO Yung LM Cao M Brown M Arons E Dieffenbach PB NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension Sci Transl Med 2018 10 445 eaap7294 10.1126/scitranslmed.aap7294 29899023
110. Fava C Montagnana M Danese E Sjögren M Almgren P Engström G Hedblad B Guidi GC Minuz P Melander O Vanin-1 T26I polymorphism, hypertension and cardiovascular events in two large urban-based prospective studies in Swedes Nutr Metab Cardiovasc Dis. 2013 23 1 53 60 10.1016/j.numecd.2011.01.012 21550219
111. Wang L Li H Yang B Guo L Han X Li L Li M Huang J Gu D The Hypertension Risk Variant Rs820430 Functions as an Enhancer of SLC4A7 Am J Hypertens. 2017 30 2 202 208 10.1093/ajh/hpw127 27784683
112. Bhupatiraju C Patkar S Pandharpurkar D Joshi S Tirunilai P Association and interaction of -58C>T and ±9 bp polymorphisms of BDKRB2 gene causing susceptibility to essential hypertension Clin Exp Hypertens. 2012 34 3 230 235 10.3109/10641963.2011.631653 22468762
113. Zhang H Sun ZQ Liu SS Yang LN Association between GRK4 and DRD1 gene polymorphisms and hypertension: a meta-analysis Clin Interv Aging. 2015 11 17 27 10.2147/CIA.S94510 26730182
114. Xu K Ma L Li Y Wang F Zheng GY Sun Z Jiang F Chen Y Liu H Dang A Genetic and Functional Evidence Supports LPAR1 as a Susceptibility Gene for Hypertension Hypertension. 2015 66 3 641 646 10.1161/HYPERTENSIONAHA.115.05515 26123684
115. Lee SM Baik J Nguyen D Nguyen V Liu S Hu Z Abbott GW Kcne2 deletion impairs insulin secretion and causes type 2 diabetes mellitus FASEB J. 2017 31 6 2674 2685 10.1096/fj.201601347 28280005
116. Deng Z Shen J Ye J Shu Q Zhao J Fang M Zhang T Association between single nucleotide polymorphisms of delta/notch-like epidermal growth factor (EGF)-related receptor (DNER) and Delta-like 1 Ligand (DLL 1) with the risk of type 2 diabetes mellitus in a Chinese Han population Cell Biochem Biophys. 2015 71 1 331 335 10.1007/s12013-014-0202-3 25300688
117. Emdin CA Khera AV Aragam K Haas M Chaffin M Klarin D Natarajan P Bick A Zekavat SM Nomura A DNA Sequence Variation in ACVR1C Encoding the Activin Receptor-Like Kinase 7 Influences Body Fat Distribution and Protects Against Type 2 Diabetes Diabetes. 2019 68 1 226 234 10.2337/db18-0857 30389748
118. Kim KS Jung Yang H Lee IS Kim KH Park J Jeong HS Kim Y Seok Ahn K The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice Sci Rep. 2015 5 18325 10.1038/srep18325 26675132
119. Mtiraoui N Turki A Nemr R Echtay A Izzidi I Al-Zaben GS Irani-Hakime N Keleshian SH Mahjoub T Almawi WY Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs Diabetes Metab. 2012 38 5 444 449 10.1016/j.diabet.2012.05.002 22749234
120. Ishii H Niiya T Ono Y Inaba N Jinnouchi H Watada H Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study Diabetol Metab Syndr. 2017 9 3 10.1186/s13098-016-0202-0 28074109
121. Jiang YD Chang YC Chiu YF Chang TJ Li HY Lin WH Yuan HY Chen YT Chuang LM SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes BMC Med Genet 2010 11 126 10.1186/1471-2350-11-126 20735855
122. Harder MN Ribel-Madsen R Justesen JM Sparsø T Andersson EA Grarup N Jørgensen T Linneberg A Hansen T Pedersen O Type 2 diabetes risk alleles near BCAR1 and in ANK1 associate with decreased β-cell function whereas risk alleles near ANKRD55 and GRB14 associate with decreased insulin sensitivity in the Danish Inter99 cohort J Clin Endocrinol Metab. 2013 98 4 E801 E806 10.1210/jc.2012-4169 23457408
123. Aruga M Tokita Y Nakajima K Kamachi K Tanaka A The effect of combined diet and exercise intervention on body weight and the serum GPIHBP1 concentration in overweight/obese middle-aged women Clin Chim Acta. 2017 475 109 115 10.1016/j.cca.2017.10.017 29056530
124. Baruch A Wong C Chinn LW Vaze A Sonoda J Gelzleichter T Chen S Lewin-Koh N Morrow L Dheerendra S Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans Proc Natl Acad Sci U S A. 2020 117 46 28992 29000 10.1073/pnas.2012073117 33139537
125. Soussi H Reggio S Alili R Prado C Mutel S Pini M Rouault C Clément K Dugail I DAPK2 Downregulation Associates With Attenuated Adipocyte Autophagic Clearance in Human Obesity Diabetes. 2015 64 10 3452 3463 10.2337/db14-1933 26038578
126. Haim Y Blüher M Konrad D Goldstein N Klöting N Harman-Boehm I Kirshtein B Ginsberg D Tarnovscki T Gepner Y ASK1 (MAP 3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype Mol Metab. 2017 6 7 725 736 10.1016/j.molmet.2017.05.003 28702328
127. Aliasghari F, Nazm SA, Yasari S, Mahdavi R, Bonyadi M. Associations of the ANKK1 and DRD2 gene polymorphisms with overweight, obesity and hedonic hunger among women from the Northwest of Iran [published online ahead of print, 2020 Feb 4]. Eat Weight Disord. 2020;10.1007/s40519-020-00851-5. doi:10.1007/s40519-020-00851-5
128. Koschinsky T Gries FA Herberg L Regulation of glycerol kinase by insulin in isolated fat cells and liver of Bar Harbor obese mice Diabetologia. 1971 7 5 316 322 10.1007/BF01219464 4109148
129. Xie J Shao Y Liu J Cui M Xiao X Gong J Xue B Zhang Q Hu X Duan H K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in mice Sci Rep. 2020 10 1 20038 10.1038/s41598-020-77096-w 33208918
130. Schwindinger WF Borrell BM Waldman LC Robishaw JD Mice lacking the G protein gamma3-subunit show resistance to opioids and diet induced obesity Am J Physiol Regul Integr Comp Physiol. 2009 297 5 R1494 R1502 10.1152/ajpregu.00308.2009 19759336
131. Founds SA Ren D Roberts JM Jeyabalan A Powers RW Follistatin-like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women Reprod Sci. 2015 22 4 402 409 10.1177/1933719114529372 24700053
132. Liu KY Sengillo JD Velez G Jauregui R Sakai LY Maumenee IH Bassuk AG Mahajan VB Tsang SH Missense mutation in SLIT2 associated with congenital myopia, anisometropia, connective tissue abnormalities, and obesity Orphanet J Rare Dis. 2018 13 1 138 10.1186/s13023-018-0885-4 30111362
133. Osorio-Conles O Guitart M Moreno-Navarrete JM Escoté X Duran X Fernandez-Real JM Gomez-Foix AM Fernández-Veledo S Vendrell J Adipose tissue and serum CCDC80 in obesity and its association with related metabolic disease Mol Med. 2017 23 225 234 10.2119/molmed.2017.00067 28850155
134. Dankel SN Røst TH Kulyté A Fandalyuk Z Skurk T Hauner H Sagen JV Rydén M Arner P Mellgren G The Rho GTPase RND3 regulates adipocyte lipolysis Metabolism. 2019 101 153999 10.1016/j.metabol.2019.153999 31672447
135. Yasui M Tamura Y Minami M Higuchi S Fujikawa R Ikedo T Nagata M Arai H Murayama T Yokode M The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity PLoS One. 2015 10 8 e0136304 10.1371/journal.pone.0136304 26308623
136. Lu F Liu Q Validation of RUNX1 as a potential target for treating circadian clock-induced obesity through preventing migration of group 3 innate lymphoid cells into intestine Med Hypotheses. 2018 113 98 101 10.1016/j.mehy.2018.02.015 29523306
137. Masaki M Kurisaki T Shirakawa K Sehara-Fujisawa A Role of meltrin {alpha} (ADAM12) in obesity induced by high- fat diet Endocrinology. 2005 146 4 1752 1763 10.1210/en.2004-1082 15637293
138. Khaidakov M Mitra S Kang BY Wang X Kadlubar S Novelli G Raj V Winters M Carter WC Mehta JL Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer PLoS One. 2011 6 5 e20277 10.1371/journal.pone.0020277 21637860
139. Matsuo Y Tanaka M Yamakage H Sasaki Y Muranaka K Hata H Ikai I Shimatsu A Inoue M Chun TH Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome Metabolism. 2015 64 11 1490 1499 10.1016/j.metabol.2015.07.016 26298466
140. Poggi M Morin SO Bastelica D Govers R Canault M Bernot D Georgelin O Verdier M Burcelin R Olive D CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice Int J Obes (Lond). 2015 39 6 977 985 10.1038/ijo.2015.26 25771927
141. Zhu Y, Wen L, Wang S, Zhang K, Cui Y, Zhang C, Feng L, Yu F, Chen Y, Wang R, et al. Omega-3 fatty acids improve flow-induced vasodilation by enhancing TRPV4 in arteries from diet-induced obese mice. Cardiovasc Res. 2020:cvaa296. 10.1093/cvr/cvaa296.
142. He L Gunn TM Bouley DM Lu XY Watson SJ Schlossman SF Duke-Cohan JS Barsh GS A biochemical function for attractin in agouti-induced pigmentation and obesity Nat Genet. 2001 27 1 40 47 10.1038/83741 11137996
143. Moreno-Navarrete JM Ortega F Gómez-Serrano M García-Santos E Ricart W Tinahones F Mingrone G Peral B Fernández-Real JM The MRC1/CD68 ratio is positively associated with adipose tissue lipogenesis and with muscle mitochondrial gene expression in humans PLoS One. 2013 8 8 e70810 10.1371/journal.pone.0070810 23951013
144. Nam JS Ahn CW Park HJ Kim YS Semaphorin 3 C is a Novel Adipokine Representing Exercise-Induced Improvements of Metabolism in Metabolically Healthy Obese Young Males Sci Rep. 2020 10 1 10005 10.1038/s41598-020-67004-7 32561824
145. Kwak SH Park BL Kim H German MS Go MJ Jung HS Koo BK Cho YM Choi SH Cho YS Association of variations in TPH1 and HTR2B with gestational weight gain and measures of obesity Obesity (Silver Spring). 2012 20 1 233 238 10.1038/oby.2011.253 21836641
146. Muñoz M López-Oliva ME Rodríguez C Martínez MP Sáenz-Medina J Sánchez A Climent B Benedito S García-Sacristán A Rivera L Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity Redox Biol. 2020 28 101330 10.1016/j.redox.2019.101330 31563085
147. Klöting N Wilke B Klöting I Alleles on rat chromosome 4 (D4Got41-Fabp1/Tacr1) regulate subphenotypes of obesity Obes Res. 2005 13 3 589 595 10.1038/oby.2005.63 15833945
148. Van Camp JK De Freitas F Zegers D Beckers S Verhulst SL Van Hoorenbeeck K Massa G Verrijken A Desager KN Van Gaal LF Investigation of common and rare genetic variation in the BAMBI genomic region in light of human obesity Endocrine. 2016 52 2 277 286 10.1007/s12020-015-0778-4 26499194
149. Zhang ZB Ruan CC Lin JR Xu L Chen XH Du YN Fu MX Kong LR Zhu DL Gao PJ Perivascular Adipose Tissue-Derived PDGF-D Contributes to Aortic Aneurysm Formation During Obesity Diabetes. 2018 67 8 1549 1560 10.2337/db18-0098 29794241
150. Suriyaprom K Pheungruang B Tungtrongchitr R Sroijit OY Relationships of apelin concentration and APLN T-1860C polymorphism with obesity in Thai children BMC Pediatr. 2020 20 1 455 10.1186/s12887-020-02350-z 32998691
151. Vaittinen M, Kolehmainen M, Rydén M, Eskelinen M, Wabitsch M, Pihlajamäki J, Uusitupa M, Pulkkinen L. MFAP5 is related to obesity-associated adipose tissue and extracellular matrix remodeling and inflammation. Obesity (Silver Spring). 2015;23(7):1371-1378. doi:10.1002/oby.21103
152. Wolff G Taranko AE Meln I Weinmann J Sijmonsma T Lerch S Heide D Billeter AT Tews D Krunic D Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis Mol Metab. 2019 19 97 106 10.1016/j.molmet.2018.10.007 30409703
153. Soomro I Hong A Li Z Duncan JS Skolnik EY Discoidin Domain Receptor 1 (DDR1) tyrosine kinase is upregulated in PKD kidneys but does not play a role in the pathogenesis of polycystic kidney disease PLoS One. 2019 14 7 e0211670 10.1371/journal.pone.0211670 31260458
154. Zeng H Qi X Xu X Wu Y TAB1 regulates glycolysis and activation of macrophages in diabetic nephropathy Inflamm Res. 2020 69 12 1215 1234 10.1007/s00011-020-01411-4 33044562
155. Zalli D Bayliss R Fry AM The Nek8 protein kinase, mutated in the human cystic kidney disease nephronophthisis, is both activated and degraded during ciliogenesis Hum Mol Genet. 2012 21 5 1155 1171 10.1093/hmg/ddr544 22106379
156. Li YB Wu Q Liu J Fan YZ Yu KF Cai Y miR-199a-3p is involved in the pathogenesis and progression of diabetic neuropathy through downregulation of SerpinE2 Mol Med Rep. 2017 16 3 2417 2424 10.3892/mmr.2017.6874 28677735
157. Zhou XJ Cheng FJ Qi YY Zhao YF Hou P Zhu L Lv JC Zhang H FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy PLoS One. 2013 8 4 e61208 10.1371/journal.pone.0061208 23593433
158. Tsai YC Kuo PL Hung WW Wu LY Wu PH Chang WA Kuo MC Hsu YL Angpt2 Induces Mesangial Cell Apoptosis through the MicroRNA-33-5p-SOCS5 Loop in Diabetic Nephropathy Mol Ther Nucleic Acids. 2018 13 543 555 10.1016/j.omtn.2018.10.003 30414568
159. Ohtsubo H Okada T Nozu K Takaoka Y Shono A Asanuma K Zhang L Nakanishi K Taniguchi-Ikeda M Kaito H Identification of mutations in FN1 leading to glomerulopathy with fibronectin deposits Pediatr Nephrol. 2016 31 9 1459 1467 10.1007/s00467-016-3368-7 27056061
160. Gerarduzzi C Kumar RK Trivedi P Ajay AK Iyer A Boswell S Hutchinson JN Waikar SS Vaidya VS Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation JCI Insight. 2017 2 8 e90299 10.1172/jci.insight.90299
161. Kim JM Wu H Green G Winkler CA Kopp JB Miner JH Unanue ER Shaw AS CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility Science. 2003 300 5623 1298 1300 10.1126/science.1081068 12764198
162. Li QS Cheng P Favis R Wickenden A Romano G Wang H SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain Severity Clin J Pain. 2015 31 11 976 982 10.1097/AJP.0000000000000205 25585270
163. Bennett CE Nsengimana J Bostock JA Cymbalista C Futers TS Knight BL McCormack LJ Prasad UK Riches K Rolton D CCAAT/enhancer binding protein alpha, beta and delta gene variants: associations with obesity related phenotypes in the Leeds Family Study Diab Vasc Dis Res. 2010 7 3 195 203 10.1177/1479164110366274 20460359
164. Domingues-Montanari S Subirana I Tomás M Marrugat J Sentí M Association between ESR2 genetic variants and risk of myocardial infarction Clin Chem. 2008 54 7 1183 1189 10.1373/clinchem.2007.102400 18487282
165. Eberlé D Clément K Meyre D Sahbatou M Vaxillaire M Le Gall A Ferré P Basdevant A Froguel P Foufelle F SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts Diabetes. 2004 53 8 2153 2157 10.2337/diabetes.53.8.2153 15277400
166. Cheng J Song J He X Zhang M Hu S Zhang S Yu Q Yang P Xiong F Wang DW Loss of Mbd2 Protects Mice Against High-Fat Diet-Induced Obesity and Insulin Resistance by Regulating the Homeostasis of Energy Storage and Expenditure Diabetes. 2016 65 11 3384 3395 10.2337/db16-0151 27554473
167. Cavallari JF, Fullerton MD, Duggan BM, Foley KP, Denou E, Smith BK, Desjardins EM, Henriksbo BD, Kim KJ, Tuinema BR, et al. Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4. Cell Metab. 2017; 25(5):1063-1074.e3. doi:10.1016/j.cmet.2017.03.021
168. Qi L Saberi M Zmuda E Wang Y Altarejos J Zhang X Dentin R Hedrick S Bandyopadhyay G Hai T Adipocyte CREB promotes insulin resistance in obesity Cell Metab. 2009 9 3 277 286 10.1016/j.cmet.2009.01.006 19254572
169. Yan X Zhu MJ Xu W Tong JF Ford SP Nathanielsz PW Du M Up-regulation of Toll-like receptor 4/nuclear factor-kappaB signaling is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese sheep at late gestation Endocrinology. 2010 151 1 380 387 10.1210/en.2009-0849 19887565
170. Matsha TE Kengne AP Hector S Mbu DL Yako YY Erasmus RT MicroRNA profiling and their pathways in South African individuals with prediabetes and newly diagnosed type 2 diabetes mellitus Oncotarget 2018 9 55 30485 30498 10.18632/oncotarget.25271 30093963
171. Ding L Ai D Wu R Zhang T Jing L Lu J Zhong L Identification of the differential expression of serum microRNA in type 2 diabetes Biosci Biotechnol Biochem. 2016 80 3 461 465 10.1080/09168451.2015.1107460 26554942
172. Hall CL Akhtar MM Sabater-Molina M Futema M Asimaki A Protonotarios A Dalageorgou C Pittman AM Suarez MP Aguilera B Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype Int J Cardiol. 2020 307 101 108 10.1016/j.Eijcard.2019.09.048 31627847
173. Salazar-Mendiguchía J Ochoa JP Palomino-Doza J Domínguez F Díez-López C Akhtar M Ramiro-León S Clemente MM Pérez-Cejas A Robledo M Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy Heart. 2020 106 17 1342 1348 10.1136/heartjnl-2020-316913 32451364
174. Xiao Y Deng Y Yuan F Xia T Liu H Li Z Chen S Liu Z Ying H Liu Y An ATF4-ATG5 signaling in hypothalamic POMC neurons regulates obesity Autophagy. 2017 13 6 1088 1089 10.1080/15548627.2017.1307488 28350524
175. Stratigopoulos G, LeDuc CA, Cremona ML, Chung WK, Leibel RL. Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J Biol Chem. 2011;286(3):2155–70. 10.1074/jbc.M110.188482.
176. Zhou JP, Ren YD, Xu QY, Song Y, Zhou F, Chen MY, Liu JJ, Chen LG, Pan JS. Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1. Biomed Res Int. 2020:4087928. 10.1155/2020/4087928.

